Other disorders of fluid, electrolyte and acid-base balance

E4_FLUIDELECTRO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87 Cause of death: ICD-10 — E87 2 out of 7 registries used, show all original rules.	15402
4. Check minimum number of events None	15402
5. Include endpoints E4_HYPEROSMHNAT E4_HYPOOSMNAT E4_ACIDOSIS E4_ALKALOSIS E4_MIXACIDBASE E4_HYPERKALAEMIA E4_HYPOKALAEMIA E4_FLUIDOVER E4_FLUIDELECTRONAS	15627
6. Filter based on genotype QC (FinnGen only)	15220

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Aliae perturbationes aequilibrii humoralis, electrolytici et acido-alkalici

NAME	E4_FLUIDELECTRO
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_HYPEROSMHNAT\|E4_HYPOOSMNAT\|E4_ACIDOSIS\|E4_ALKALOSIS\|E4_MIXACIDBASE\|E4_HYPERKALAEMIA\|E4_HYPOKALAEMIA\|E4_FLUIDOVER\|E4_FLUIDELECTRONAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E87
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E87
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of fluid, electrolyte and acid-base balance based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	135674	82514	52202
Only index persons	114174	70187	43987
Unadjusted period prevalence (%)
Whole population	2.01	2.36	1.46
Only index persons	2.23	2.58	1.68
Median age at first event (years)
Whole population	72.18	75.73	66.59
Only index persons	72.02	75.45	66.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	15220	8401	6819
Unadjusted period prevalence (%)	3.04	2.98	3.12
Median age at first event (years)	69.55	69.80	69.24

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15627: Matched controls
148788

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N17.8

ICD-10 Finland

Other acute renal failure

8.6

317.5

419

475

C10AA01

ATC

simvastatin; oral

1.9

308.8

7049

45200

N06AB04

ATC

citalopram; systemic

2.1

308.7

3665

18747

N03AX16

ATC

[U] pregabalin

2.1

308.2

4032

21388

N19

ICD-10 Finland

Unspecified kidney failure

4.6

307.7

990

2174

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.0

307.7

3221

11924

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

11234

79681

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.1

307.7

962

1890

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.9

307.7

3523

13679

AA1AD

NOMESCO Finland

CT of head and brain

3.3

307.7

6522

26563

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.0

307.7

795

1128

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

3314

13301

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

307.7

4116

21247

C03CA01

ATC

furosemide; systemic

3.6

307.7

8142

34614

TK800

NOMESCO Finland

Hemodialysis

7.3

307.7

661

899

L28

ICPC

Limited function/disability (L)

2.4

307.7

3724

17012

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.7

307.7

664

984

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

13.2

307.7

561

418

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

307.7

5868

29044

R53

ICD-10 Finland

Malaise and fatigue

3.1

307.7

5290

21279

N03AX14

ATC

levetiracetam; systemic

4.9

307.7

755

1522

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.3

307.7

717

976

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

407.3

307.7

537

N06AX11

ATC

mirtazapine; oral

2.3

307.7

6082

32828

R06.0

ICD-10 Finland

Dyspnoea

2.2

307.7

4889

25772

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

307.7

4373

21770

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.3

307.7

691

1285

N07BB01

ATC

disulfiram; oral

4.7

307.7

973

2080

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

307.7

9110

49910

N05BA01

ATC

diazepam; systemic, rectal

2.4

307.7

2584

11179

B01AC04

ATC

clopidogrel; oral

2.4

307.7

2869

12741

I10

ICD-10 Finland

Essential (primary) hypertension

2.7

307.7

11298

72507

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

307.7

6421

37460

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

307.7

2125

7674

ZXD05

NOMESCO Finland

Urgent procedure

2.2

307.7

5220

27991

E83.51

ICD-10 Finland

Hypocalcemia

68.8

307.7

235

A10AE04

ATC

insulin glargine; parenteral

3.4

307.7

2085

6472

E87.6

ICD-10 Finland

Hypokalaemia

151.0

307.7

5315

506

F10.24

ICD-10 Finland

Alcohol depence active use

10.0

307.7

522

514

H02AB09

ATC

hydrocortisone; systemic

6.5

307.7

684

1034

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

307.7

3261

14007

N17.9

ICD-10 Finland

Acute renal failure, unspecified

8.3

307.7

1789

2282

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

307.7

6346

33327

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

11.1

307.7

445

393

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

307.7

5848

26504

C08CA13

ATC

lercanidipine; oral

2.4

307.7

2921

13137

N05AH04

ATC

quetiapine; oral

2.9

307.7

3376

12987

205

Kela drug reimbursment

Chronic hypertension

2.3

307.7

5738

29894

SPAT1262

SPAT

Handing over of treatment supplies

2.3

307.7

3328

15595

N05CF01

ATC

zopiclone; oral

2.1

307.7

6160

34890

E87.5

ICD-10 Finland

Hyperkalaemia

115.4

307.7

2455

240

F10.25

ICD-10 Finland

Alcohol dependence continuous use

9.4

307.7

663

701

E86

ICD-10 Finland

Volume depletion

73.9

307.7

1044

144

R11

ICD-10 Finland

Nausea and vomiting

4.1

307.7

2274

5994

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.3

307.7

1473

2843

WX892

NOMESCO Finland

Monitored bed care

3.5

307.7

1743

5207

I50.9

ICD-10 Finland

Heart failure, unspecified

3.3

307.7

3991

14071

E87.2

ICD-10 Finland

Acidosis

1861.9

307.7

783

103

Kela drug reimbursment

Diabetes, insulin-treated

2.2

307.7

5018

26311

SPAT1254

SPAT

Administration of medicine

2.5

307.7

3161

13573

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.4

307.7

1852

4370

C08CA01

ATC

amlodipine; oral

2.6

307.7

7932

41993

A04

ICPC

Weakness/tiredness general

2.4

307.7

2780

12238

A10AB05

ATC

insulin aspart; parenteral

3.9

307.7

1745

4691

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

307.7

2430

8927

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

307.7

2575

8053

A11CC03

ATC

alfacalcidol; systemic

6.9

307.7

658

938

N05BA04

ATC

oxazepam; oral

2.3

307.7

4948

24545

D64.9

ICD-10 Finland

Anaemia, unspecified

3.3

307.7

2833

9341

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

6.7

307.7

1478

2293

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

307.7

2994

10686

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

10.0

307.7

486

475

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.8

307.7

903

1882

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

307.7

2865

12492

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.9

307.7

595

852

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

10.3

307.7

378

356

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

307.7

5198

16584

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.8

307.7

1283

3395

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

307.7

1412

4072

A28

ICPC

Limited function/disability NOS

2.7

307.7

4072

16954

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

307.7

2230

7709

C02AC05

ATC

moxonidine; oral

4.0

307.7

1163

2923

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.2

307.7

4103

20729

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.6

307.7

1225

3403

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

7.7

307.7

504

642

N05AH03

ATC

olanzapine; systemic

3.5

307.7

1229

3518

I50.0

ICD-10 Finland

Congestive heart failure

3.2

307.7

2027

6680

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.2

307.7

2210

3872

N02AA05

ATC

oxycodone; systemic

2.5

307.7

3912

17707

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

385.9

307.7

8121

416

C03DA01

ATC

spironolactone; oral

4.2

307.7

3733

10347

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

307.7

1683

5864

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.4

307.7

2935

9502

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

307.7

4213

19504

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

12.0

307.7

476

387

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.8

307.7

4379

13938

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

101.4

307.7

272

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

307.7

4650

22435

A06AD11

ATC

lactulose; oral

2.6

307.7

3491

14910

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.4

307.7

3091

10174

N18.8

ICD-10 Finland

Other chronic renal failure

5.8

307.7

737

1264

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

307.7

2366

8628

P15

ICPC

Chronic alcohol abuse

6.0

307.7

783

1289

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

307.7

1442

3983

C07AB07

ATC

bisoprolol; oral

2.5

307.7

9428

55786

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

12.3

307.7

353

279

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

307.7

3026

13862

V03AE01

ATC

polystyrene sulfonate; oral

10.6

307.7

530

492

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

3225

14804

N03AG01

ATC

valproic acid; systemic, rectal

3.7

307.7

1307

3617

A10AC01

ATC

insulin (human); parenteral

3.0

303.7

1514

5185

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.6

302.8

502

740

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.7

300.8

1894

7338

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

300.2

1496

5121

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.1

299.9

1417

4706

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.6

299.9

595

1048

N30.0

ICD-10 Finland

Acute cystitis

2.2

298.7

2945

13974

R55

ICD-10 Finland

Syncope and collapse

2.5

298.6

2256

9537

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.2

298.1

527

830

T90

ICPC

Diabetes non-insulin dependent

2.0

296.4

4093

22096

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

295.6

4400

24392

R41.0

ICD-10 Finland

Disorientation, unspecified

4.1

295.4

872

2133

JN4AD

NOMESCO Finland

Body CT examination

2.5

292.5

2101

8669

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.0

289.4

406

496

C09AA05

ATC

ramipril; oral

2.0

288.5

4526

25516

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.1

288.4

3732

19648

J01MA02

ATC

ciprofloxacin; systemic

1.9

287.6

6646

42489

N05AA02

ATC

levomepromazine; systemic

3.8

285.9

917

2380

A12BA01

ATC

potassium chloride; oral

3.2

285.1

1204

3739

C01DA14

ATC

isosorbide mononitrate; oral

2.2

284.9

2997

14570

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

284.9

1508

5331

A12AA04

ATC

calcium carbonate; oral

7.2

282.0

435

593

N05CD07

ATC

temazepam; oral

2.3

279.1

2542

11642

R60.0

ICD-10 Finland

Localized oedema

2.3

278.7

2424

10885

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.3

277.9

488

763

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

277.7

919

2437

S97

ICPC

Chronic ulcer skin

3.0

276.5

1355

4588

A46

ICD-10 Finland

Erysipelas

2.2

274.5

2810

13494

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

270.3

3117

15672

J01MA12

ATC

levofloxacin; systemic

2.1

269.0

3385

17580

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.4

268.5

1028

3001

A10AE05

ATC

insulin detemir; parenteral

3.4

268.2

1025

2989

N05AX08

ATC

risperidone; systemic

2.6

267.9

1775

7031

C07AB02

ATC

metoprolol; systemic

2.0

267.8

3843

20919

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

265.0

3137

15916

R42

ICD-10 Finland

Dizziness and giddiness

2.0

264.3

4063

22632

B03XA02

ATC

darbepoetin alfa; parenteral

5.3

262.3

548

1011

127

Kela drug reimbursment

Transplant complication

7.2

261.8

402

545

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

261.7

1709

6718

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

260.7

1362

4772

M04AA01

ATC

allopurinol; systemic

2.2

260.1

2548

11997

F05.9

ICD-10 Finland

Delirium, unspecified

4.8

259.6

615

1265

A10BA02

ATC

metformin; oral

1.9

259.2

4738

27914

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

258.5

886

2404

N02AX02

ATC

tramadol; systemic, rectal

1.8

258.5

6987

46372

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

258.3

4311

24654

R50.9

ICD-10 Finland

Fever, unspecified

2.2

258.2

2603

12395

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

257.5

5495

33971

N02BE01

ATC

paracetamol; systemic, rectal

2.4

256.8

13830

113797

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.1

256.5

463

744

R33

ICD-10 Finland

Retention of urine

2.6

253.8

1700

6761

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

9.6

253.1

306

309

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

251.3

2800

13853

P16

ICPC

Acute alcohol abuse

6.7

250.0

408

591

UJF32

NOMESCO Finland

Coloscopy

1.9

248.3

4528

26589

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.4

246.9

1867

7854

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.9

245.7

271

240

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

244.8

1090

3486

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.3

244.7

369

490

Z94.0

ICD-10 Finland

Kidney transplant status

8.6

244.1

321

362

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

243.4

4497

26485

C03AA03

ATC

hydrochlorothiazide; oral

2.4

243.3

1898

8094

T89

ICPC

Diabetes insulin dependent

4.1

242.4

690

1640

G72.8

ICD-10 Finland

Other specified myopathies

5.6

241.5

478

839

N03AF02

ATC

oxcarbazepine; oral

4.0

241.3

714

1746

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.1

238.0

245

195

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

237.2

1912

8268

H02AB06

ATC

prednisolone; systemic

1.7

233.7

7585

52513

N06AX16

ATC

venlafaxine; oral

2.3

233.5

2071

9327

C09AA02

ATC

enalapril; systemic

1.9

232.6

3617

20097

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

232.2

872

2510

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

231.6

2992

15589

SPAT1229

SPAT

Assessment of need for aid

2.5

231.4

1668

6853

ZX120

NOMESCO Finland

Intravenous

2.4

231.3

1729

7223

J01DB01

ATC

cefalexin; oral

1.9

229.7

12492

100093

L04AD02

ATC

tacrolimus; systemic

9.5

229.1

278

282

SPAT1216

SPAT

Assessment of functional ability

2.0

228.9

3021

15855

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.8

228.1

533

1083

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.7

227.3

295

327

SPAT1263

SPAT

Sampling

1.7

227.1

6554

43812

WX872

NOMESCO Finland

Intensive care

3.2

226.5

988

3118

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.4

226.4

865

2517

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

223.8

4618

28004

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

222.7

3683

20839

S06.0

ICD-10 Finland

Concussion

2.3

222.5

1875

8252

AN1

Coronary angiography

2.3

221.4

1880

8301

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

42.4

220.1

137

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.0

219.8

647

1575

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

11.4

218.6

234

198

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.7

218.6

522

1080

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

217.6

1665

7020

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.0

216.9

303

368

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

10.7

216.9

242

218

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

215.8

1802

7895

SPAT1301

SPAT

No procedures

1.8

215.5

5205

32972

L04AA06

ATC

mycophenolic acid; systemic

5.5

214.0

430

765

K70.1

ICD-10 Finland

Alcoholic hepatitis

11.0

212.8

233

204

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.6

212.0

256

258

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.9

210.5

480

955

N05BA06

ATC

lorazepam; systemic, sublingual

2.8

210.3

1119

3946

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

209.7

1464

5915

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

209.5

1416

5634

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.0

208.4

982

3238

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

207.9

1974

9117

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

207.5

2995

16151

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

206.9

1309

5043

R63.1

ICD-10 Finland

Polydipsia

22.9

206.7

155

N03AX09

ATC

lamotrigine; oral

3.5

205.5

741

2075

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

205.3

1807

8087

137

Kela drug reimbursment

Uraemia requiring dialysis

9.1

204.6

257

273

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

13.3

203.8

198

143

N06AX21

ATC

duloxetine; oral

2.3

203.4

1834

8289

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.6

201.4

704

1931

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.5

201.0

337

502

WX882

NOMESCO Finland

High dependency care

3.9

200.6

627

1593

Z51.5

ICD-10 Finland

Palliative care

2.3

200.6

1644

7133

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

198.6

1352

5392

Z2446

NOMESCO Finland

Social worker

2.8

197.9

1111

4027

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.7

197.6

658

1747

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

197.3

3511

20222

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

197.2

1026

3572

N05AF03

ATC

chlorprothixene; systemic

4.2

194.8

536

1240

C10AA05

ATC

atorvastatin; oral

1.7

194.1

6177

41865

A10BH01

ATC

sitagliptin; oral

2.3

194.0

1655

7300

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.8

194.0

615

1578

SPAT1234

SPAT

Support of social functional capacity

2.7

193.9

1127

4158

B01AA03

ATC

warfarin; systemic

1.8

192.8

3568

20780

B05DA

ATC

Isotonic solutions

10.0

190.6

223

215

WW500

NOMESCO Finland

Blood transfusion

3.1

189.4

843

2687

C08CA02

ATC

felodipine; oral

2.2

189.0

1856

8669

J01FF01

ATC

clindamycin; systemic

1.8

188.7

4148

25390

A10BH05

ATC

linagliptin; oral

2.8

186.9

1009

3580

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

186.2

1212

4727

N03AX12

ATC

[U] gabapentin; oral

1.9

185.7

2594

13783

W19

ICD-10 Finland

Unspecified fall

2.2

185.2

1771

8180

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.7

184.9

622

1662

Z3231

NOMESCO Finland

Registered nurse

1.7

183.1

4211

26066

Z49.2

ICD-10 Finland

Other dialysis

9.8

182.5

217

214

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

6.0

181.8

332

539

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

20.7

181.6

142

N06AB10

ATC

escitalopram; oral

1.9

181.2

2721

14798

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

180.4

2007

9824

B05DB

ATC

Hypertonic solutions

10.3

180.3

206

192

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

178.3

2467

13049

A10AB01

ATC

insulin (human); parenteral

3.6

177.7

604

1625

E0000UV, ,

ATC

1.6

177.4

6155

42361

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

177.1

1190

4709

WX730

NOMESCO Finland

Conventional respirator

5.0

176.2

393

767

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.7

176.0

338

576

N05BA02

ATC

chlordiazepoxide; systemic

3.9

175.9

539

1349

E83.50

ICD-10 Finland

Hypercalcemia

9.0

175.5

222

238

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

175.0

4656

29914

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.9

174.7

2890

16195

N03AF01

ATC

carbamazepine; oral, rectal

2.7

174.3

982

3560

B01AB05

ATC

enoxaparin; parenteral

1.7

173.7

5002

32796

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

172.8

1675

7767

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.1

172.0

760

2410

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

12.9

171.5

170

127

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

171.0

3874

23801

S01.0

ICD-10 Finland

Open wound of scalp

2.3

170.9

1458

6416

K92.1

ICD-10 Finland

Melaena

2.6

170.8

1066

4069

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

170.7

1379

5928

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

169.9

342

609

C09CA01

ATC

losartan; oral

1.7

169.2

4188

26351

I95.1

ICD-10 Finland

Orthostatic hypotension

3.0

168.3

808

2687

J01EA01

ATC

trimethoprim; systemic

1.7

168.2

4195

26441

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

168.2

5261

35162

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.2

167.5

255

342

R4110

NOMESCO Finland

Physiotherapy

1.7

166.6

4071

25506

N06AB06

ATC

sertraline; oral

2.2

166.0

1597

7378

R03BB04

ATC

tiotropium bromide; inhalant

2.1

165.7

1849

9043

V03AE02

ATC

sevelamer; oral

11.6

164.0

173

143

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

163.5

1357

5897

R02

ICPC

Shortness of breath/dyspnoea

2.0

162.2

2099

10822

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

162.1

1430

6375

A10BB12

ATC

glimepiride; oral

2.3

162.0

1307

5611

R51.80

ICD-10 Finland

Headache

2.0

162.0

2069

10619

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

161.8

2866

16360

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.1

161.7

703

2207

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

161.6

704

2213

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

161.1

1022

3929

N18.0

ICD-10 Finland

End-stage renal disease

6.3

160.9

279

430

207

Kela drug reimbursment

Chronic arrhythmias

1.8

160.9

2830

16118

K92.0

ICD-10 Finland

Haematemesis

3.6

159.8

555

1514

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

159.5

1104

4423

A10AB04

ATC

insulin lispro; parenteral

3.9

158.4

493

1247

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

156.7

1057

4184

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

8.8

156.1

200

218

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

156.0

5803

40259

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.4

155.4

403

890

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

154.1

2866

16575

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

9.6

153.4

185

186

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.0

153.4

238

326

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

153.1

841

3005

C07AG02

ATC

carvedilol; oral

2.4

152.2

1106

4529

TK810

NOMESCO Finland

Hemofiltration

9.7

152.1

182

181

M10.9

ICD-10 Finland

Gout, unspecified

2.3

151.4

1191

5052

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.7

151.1

494

1293

I50

ICD-10 Finland

Heart failure

3.0

150.9

703

2296

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.5

150.7

540

1503

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

150.5

1077

4379

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.2

149.7

640

1989

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

148.2

2116

11253

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

147.9

2842

16570

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.5

147.9

1035

4164

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

9.3

147.1

181

187

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

147.0

4090

26358

SPAT1255

SPAT

Intravenous administration of medicine

2.3

146.8

1200

5173

N03AX18

ATC

lacosamide; systemic

7.7

146.6

209

260

A02BC01

ATC

omeprazole; systemic

1.6

146.5

4306

28128

A29

ICPC

General symptom/complaint other

1.9

145.9

2094

11151

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

145.3

1338

6060

J01CA08

ATC

pivmecillinam; oral

1.6

144.5

5747

40296

Z72.1

ICD-10 Finland

Alcohol use

5.5

143.9

283

493

B01AF02

ATC

apixaban; oral

1.9

143.8

2197

11935

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

7.1

143.6

221

300

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

9.6

143.4

173

174

R18

ICD-10 Finland

Ascites

3.8

143.4

456

1171

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

143.4

1661

8212

H3603, E103,

ICD-10 Finland

8.3

143.0

192

222

N05AX12

ATC

aripiprazole; systemic

3.5

142.4

514

1437

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

142.3

630

1998

E26.0

ICD-10 Finland

Primary hyperaldosteronism

8.3

141.9

190

219

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

141.3

822

3023

196

Kela drug reimbursment

Paricalcitol and cinacalcet

11.7

141.3

148

121

I25.2

ICD-10 Finland

Old myocardial infarction

2.4

141.3

1097

4623

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.6

141.1

158

143

SPAT1167

SPAT

Insertion of urinary catheter

2.9

140.6

689

2314

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

140.6

5742

40436

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.3

140.6

565

1691

I20.09

ICD-10 Finland

Unstable angina

2.5

140.3

928

3634

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.8

140.2

223

314

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.9

140.1

423

1047

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

139.8

692

2337

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

139.6

788

2854

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

138.8

1001

4081

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

138.5

2380

13399

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

138.1

1097

4668

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.1

137.8

190

227

A02BC05

ATC

esomeprazole; systemic

1.5

136.2

5959

42524

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.4

135.7

353

781

I95.9

ICD-10 Finland

Hypotension, unspecified

4.4

134.7

347

762

J01MA14

ATC

moxifloxacin; systemic

2.1

134.6

1456

7012

A01

ICPC

Pain general/multiple sites

2.1

134.4

1467

7087

N06AA09

ATC

amitriptyline; systemic

2.0

134.4

1595

7945

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

134.3

1649

8314

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.9

134.2

673

2289

I50.1

ICD-10 Finland

Left ventricular failure

2.4

133.3

948

3838

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

132.8

2545

14779

WZC30

NOMESCO Finland

Teaching

1.8

132.4

2364

13447

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.9

132.1

396

975

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

131.2

861

3357

N05AH02

ATC

clozapine; systemic

4.8

131.0

302

606

SPAT1260

SPAT

Consultation of another employee

1.7

130.9

2769

16529

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

130.6

918

3696

E87

ICD-10 Finland

Other disorders of fluid, electrolyte and acid-base balance

70.8

130.6

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.7

129.9

435

1157

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

260.3

129.8

135

P29

ICPC

Psychological sympt/compl other

2.5

129.1

830

3205

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

128.7

2104

11645

H04AA01

ATC

glucagon; nasal, parenteral

4.5

128.6

323

695

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.9

128.6

630

2115

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.3

128.0

158

164

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

127.8

2652

15734

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

127.7

1322

6256

C07AA05

ATC

propranolol; systemic

1.7

127.5

2711

16191

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.4

127.2

475

1357

SPAT1240

SPAT

Therapeutic discussion

2.1

127.0

1277

5976

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

13.9

126.5

120

A07AA09

ATC

vancomycin; oral

4.4

126.3

327

721

K08.3

ICD-10 Finland

Retained dental root

2.1

126.2

1244

5776

SPAT1125

SPAT

Stoma care and guidance

3.7

126.0

407

1056

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

125.9

5233

36758

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

125.7

511

1539

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

125.4

907

3699

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

125.2

671

2364

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.7

125.0

178

221

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.5

124.7

447

1244

JN4BD

NOMESCO Finland

Extensive body CT

1.9

124.3

1785

9475

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.2

124.1

1112

4971

A10AA01, ,

ATC

3.8

124.0

397

1024

UKC02

NOMESCO Finland

Cystoscopy

1.7

123.8

2650

15842

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

123.8

2051

11387

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

123.7

2447

14312

XF404

NOMESCO Finland

Ambulatory ECG

2.0

123.6

1390

6781

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

9.9

123.0

144

139

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

122.4

3243

20496

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.6

122.3

765

2913

K07

ICPC

Swollen ankles/oedema

2.4

122.2

879

3574

N06AB03

ATC

fluoxetine; oral

1.9

122.0

1762

9367

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.4

120.9

315

698

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.3

120.5

247

447

R4190

NOMESCO Finland

Nutritional therapy

3.0

120.5

562

1835

ZY010

NOMESCO Finland

Hospital outpatient

2.7

120.4

672

2417

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.3

120.2

208

320

A41.8

ICD-10 Finland

Other specified sepsis

3.7

119.9

391

1021

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

10.4

119.3

135

124

Z3226

NOMESCO Finland

Physiotherapist

1.7

119.2

2589

15523

E23.00

ICD-10 Finland

Panhypopituitarism

10.8

118.7

131

116

SPAT1265

SPAT

Breathalyser

6.3

118.6

204

312

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

11.5

118.0

125

104

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.8

117.4

368

935

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.6

117.4

397

1063

A10AE06

ATC

insulin degludec; parenteral

3.2

117.2

496

1530

N06AX03

ATC

mianserin; oral

2.4

117.1

824

3316

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

116.8

1522

7812

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

116.8

1080

4885

H03AA01

ATC

levothyroxine sodium; systemic

1.6

116.7

3299

21151

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.9

116.3

355

885

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

115.8

1190

5608

H02AA02

ATC

fludrocortisone; oral

5.4

115.7

233

415

N02BF02

ATC

pregabalin; oral

2.4

115.6

875

3638

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.1

115.3

329

781

SPAT1252

SPAT

Overall medication plan or its review

2.1

115.0

1212

5767

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

114.9

6948

52414

N05BE01

ATC

buspirone; oral

3.1

114.8

499

1564

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

114.8

4380

30066

TK820

NOMESCO Finland

Peritoneal dialysis

9.7

113.6

135

133

WX002

NOMESCO Finland

Sedation and analgesia

1.6

113.3

2897

18101

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

113.0

5572

40324

2768A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]

+∞

112.6

110

E87.7

ICD-10 Finland

Fluid overload

280.0

112.0

116

B01AB10

ATC

tinzaparin; parenteral

1.9

111.8

1511

7846

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.9

111.8

338

837

105

Kela drug reimbursment

Adrenal cortical hypofunction

15.4

111.8

100

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

111.2

716

2763

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

12.7

111.1

111

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

9.1

111.0

139

147

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

110.9

9590

77280

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

110.7

1556

8185

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

110.5

1175

5607

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

110.4

870

3681

C09BA02

ATC

enalapril and diuretics; systemic

2.0

110.3

1384

7008

R03AC02

ATC

salbutamol; inhalant

1.5

110.1

7453

57281

R5110, ,

SPAT

2.1

110.0

1073

4954

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

9.1

109.1

136

143

N06AA12

ATC

doxepin; systemic

2.3

108.4

888

3819

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.3

108.2

885

3803

C09CA03

ATC

valsartan; oral

1.9

108.0

1485

7751

N05BA12

ATC

alprazolam; oral

1.9

107.8

1478

7708

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

7.0

107.5

168

232

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

107.2

6166

45862

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

107.1

1818

10137

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.0

107.0

1192

5784

V03AA01, ,

ATC

4.0

106.9

317

774

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

106.9

422

1248

ZXE00

NOMESCO Finland

One hour or less

1.5

106.7

5385

39033

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.9

106.7

321

792

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.7

105.9

608

2217

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.2

105.9

434

1313

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.2

105.8

1004

4584

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.6

105.6

366

996

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

105.5

3709

24920

M54.5

ICD-10 Finland

Low back pain

1.5

105.4

4706

33266

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

105.3

1022

4707

S18

ICPC

Laceration/cut

1.5

105.0

6653

50336

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

5.1

104.8

226

428

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

104.8

1147

5529

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

104.6

952

4275

N03AE01

ATC

clonazepam; systemic

2.2

104.4

912

4028

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

104.3

364

995

A10AA02, ,

ATC

2.8

103.7

532

1829

ZY000

NOMESCO Finland

Hospital inpatient

5.1

103.5

223

422

N04AA02

ATC

biperiden; systemic

3.5

103.5

360

982

H3600, E103,

ICD-10 Finland

6.5

103.4

171

251

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.3

103.4

405

1192

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

103.2

882

3859

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

103.1

2109

12397

M05BX04

ATC

denosumab; parenteral

2.1

103.0

1087

5167

N05CF02

ATC

zolpidem; oral

1.7

102.8

2358

14291

183

Kela drug reimbursment

Lamotrigin and topiramate

5.8

102.2

190

314

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

101.8

640

2441

N05AB03

ATC

perphenazine; systemic, rectal

2.7

101.3

556

1981

K59.0

ICD-10 Finland

Constipation

2.2

101.3

961

4386

A02BC03

ATC

lansoprazole; oral

1.5

101.2

4270

29782

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

100.9

1122

5436

H36.01

ICD-10 Finland

Diabetic maculopathy

4.7

100.9

241

498

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.5

100.9

674

2646

P99

ICPC

Psychological disorders other

3.3

100.3

395

1166

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

100.1

1101

5313

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.1

99.9

441

1394

A08

ICPC

Swelling

2.2

99.9

862

3786

Z71.8

ICD-10 Finland

Other specified counselling

1.5

99.9

3851

26345

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

7.9

99.7

140

171

N05AD01

ATC

haloperidol; systemic

2.6

99.0

606

2281

K77

ICPC

Heart failure

3.0

98.8

455

1474

SPAT1310

SPAT

Counselling related to known health issue

1.5

98.6

4487

31747

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.7

98.4

324

852

EBA00

NOMESCO Finland

Extraction of tooth

1.5

98.1

4671

33341

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

97.8

4696

33569

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.1

97.2

211

402

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.1

97.2

211

402

J96.0

ICD-10 Finland

Acute respiratory failure

4.0

97.2

283

682

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.9

97.1

295

733

SPAT1211

SPAT

Application of soft bandage

1.9

96.9

1373

7226

Y94.0

ICD-10 Finland

Accident at home

3.3

96.9

370

1072

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.4

96.4

109

100

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.3

95.9

750

3159

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

95.9

1302

6757

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.6

95.9

322

858

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

95.9

579

2165

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

95.7

996

4708

F50.0

ICD-10 Finland

Anorexia nervosa

11.2

95.6

103

M79.6

ICD-10 Finland

Pain in limb

1.4

95.5

5596

41499

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

95.5

920

4221

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

95.5

1278

6600

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.4

95.1

245

538

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

7.2

95.1

144

192

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

94.7

618

2399

P01AB01

ATC

metronidazole; oral, rectal

1.4

94.5

5292

38899

H05BX01

ATC

cinacalcet; oral

6.8

94.4

150

211

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.5

94.4

157

232

P72

ICPC

Schizophrenia

3.7

94.0

303

785

C08CA05

ATC

nifedipine; systemic

2.0

93.4

1052

5118

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.3

93.3

190

342

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

93.2

718

3005

J01DA01

ATC

[U] cefalexin

1.4

93.0

8702

70011

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

93.0

445

1473

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.1

92.9

265

629

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

92.8

1848

10760

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.0

92.7

205

397

I20.00

ICD-10 Finland

Unstable angina

2.8

92.4

485

1688

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

91.9

938

4400

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.1

91.8

196

368

3025

Kela drug reimbursment

Calcium carbonate

8.5

91.7

121

137

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

91.6

803

3547

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

7.3

91.3

136

178

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.6

91.3

559

2104

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

91.3

664

2709

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

91.2

1747

10059

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

14.6

91.2

E87.3

ICD-10 Finland

Alkalosis

870.5

91.2

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.0

91.0

267

647

NHQ40

NOMESCO Finland

Amputation of toe

3.5

91.0

328

916

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

90.9

705

2958

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.4

90.9

154

232

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.2

90.6

250

579

E000001, ,

ATC

1.6

90.6

2711

17484

OAB43, ,

SPAT

0.5

90.5

795

15057

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

8.7

90.5

117

129

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.5

90.5

604

2369

H02AB04

ATC

methylprednisolone; systemic

1.7

90.2

2111

12824

S72.0

ICD-10 Finland

Fracture of neck of femur

2.2

90.1

793

3508

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

90.0

1171

5988

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

89.8

518

1893

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

89.5

381

1179

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

9.2

89.5

111

116

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

12.3

89.4

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.0

89.2

407

1311

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

89.1

1204

6233

P03

ICPC

Feeling depressed

2.0

88.9

1007

4906

E61.2

ICD-10 Finland

Magnesium deficiency

25.5

88.7

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

88.5

927

4389

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

88.5

888

4137

SPAT1097

SPAT

Recording of ECG

1.6

88.2

2248

13945

R40.2

ICD-10 Finland

Coma, unspecified

4.8

88.0

205

415

N05AF05

ATC

zuclopenthixol; systemic

4.8

87.5

202

406

F61.0

ICD-10 Finland

Mixed personality disorders

4.2

87.4

239

550

F34.1

ICD-10 Finland

Dysthymia

2.7

87.3

471

1663

N05AN01

ATC

lithium; oral

3.2

87.0

349

1042

V03AE03

ATC

lanthanum carbonate; oral

9.8

87.0

103

101

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

86.6

5451

40753

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

86.3

581

2287

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

86.3

665

2782

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.4

86.2

615

2487

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.3

86.1

331

963

A02BA02

ATC

ranitidine; systemic

1.5

85.8

2914

19305

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

85.4

1486

8315

102

Kela drug reimbursment

Diabetes insipidus

13.8

85.4

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

12.2

85.4

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.6

85.3

292

788

R04.0

ICD-10 Finland

Epistaxis

1.9

85.2

1190

6224

K56.7

ICD-10 Finland

Ileus, unspecified

3.3

85.0

337

999

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.1

85.0

816

3736

SPAT1172

SPAT

Guidance concerning hydration

2.7

84.7

472

1694

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

3.6

84.6

287

770

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

84.6

1412

7805

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.0

84.4

184

352

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.2

84.3

710

3084

SPAT1104

SPAT

Monitoring of emergency patient

2.0

84.0

1027

5137

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

16.2

83.7

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

10.9

83.7

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

83.7

1046

5272

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.2

83.5

146

227

A07AA02

ATC

nystatin; oral

2.0

83.4

964

4728

U04

ICPC

Incontinence urine

2.0

83.3

907

4354

C01AA05

ATC

digoxin; systemic

1.8

83.0

1473

8288

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.7

82.9

274

722

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

82.7

580

2326

G40

ICD-10 Finland

Epilepsy

5.0

82.6

181

348

C09CA06

ATC

candesartan; oral

1.5

82.3

3230

22037

P20

ICPC

Memory disturbance

1.6

81.9

2266

14315

XF402

NOMESCO Finland

ECG with work load test

1.8

81.8

1416

7908

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

81.7

340

1038

U05

ICPC

Urination problems other

2.1

81.6

831

3891

WVA20

NOMESCO Finland

Medicine administration

2.8

81.5

413

1410

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.2

81.3

333

1007

Angiography of the heart and coronary arteries

2.0

81.2

926

4519

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

81.2

310

898

N06AX26

ATC

vortioxetine; oral

2.1

81.1

829

3887

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.4

80.9

573

2308

A04AA01

ATC

ondansetron; systemic, rectal

1.9

80.9

1179

6247

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

80.9

936

4592

D64.8

ICD-10 Finland

Other specified anaemias

3.2

80.8

338

1035

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.7

80.6

438

1552

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.6

80.5

486

1816

ZXA05

NOMESCO Finland

Left side

1.5

80.4

3599

25192

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

80.4

721

3213

R07.3

ICD-10 Finland

Other chest pain

1.8

80.3

1392

7774

N05BA09

ATC

clobazam; oral

6.9

80.3

126

175

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

80.2

902

4379

S70.0

ICD-10 Finland

Contusion of hip

2.3

80.1

648

2767

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.8

80.1

182

361

WX402

NOMESCO Finland

General anaesthesia

1.5

80.0

2598

17013

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

80.0

5987

45932

E66.8

ICD-10 Finland

Other obesity

2.4

79.9

581

2368

F50.9

ICD-10 Finland

Eating disorder, unspecified

6.9

79.8

126

176

J01CF05

ATC

flucloxacillin; systemic

2.1

79.7

827

3898

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

79.7

969

4836

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

4.6

79.6

194

408

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.9

79.5

240

594

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.5

79.4

131

192

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.7

79.3

431

1527

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

8.7

79.2

102

112

R52.9

ICD-10 Finland

Pain, unspecified

1.8

79.1

1321

7296

D11

ICPC

Diarrhoea

1.8

79.0

1357

7558

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

79.0

646

2771

H3601, E103,

ICD-10 Finland

6.0

79.0

141

224

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

78.9

1547

8945

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

78.8

784

3638

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

78.8

466

1724

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.3

78.5

208

467

P76

ICPC

Depressive disorder

2.2

78.5

700

3111

L17

ICPC

Foot/toe symptom/complaint

1.4

78.5

3855

27444

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

78.4

472

1761

JAH00

NOMESCO Finland

Laparotomy

2.6

78.0

483

1827

C09DA01

ATC

losartan and diuretics; oral

1.7

77.8

1598

9357

N05AA01

ATC

chlorpromazine; systemic, rectal

4.0

77.7

228

553

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

77.6

577

2375

N05AB01

ATC

dixyrazine; systemic

3.8

77.4

242

614

K65.0

ICD-10 Finland

Acute peritonitis

3.8

77.4

238

597

M05BA04

ATC

alendronic acid; oral

1.7

77.3

1533

8891

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

77.2

1455

8319

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

76.8

719

3258

K29.2

ICD-10 Finland

Alcoholic gastritis

9.9

76.8

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

76.8

770

3583

ZXA00

NOMESCO Finland

Right side

1.4

76.7

3823

27267

SPAT1251

SPAT

Organisation of medication

2.3

76.7

594

2489

E23.03

ICD-10 Finland

Lack of ACTH

12.0

76.6

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

76.5

294

855

P01

ICPC

Feeling anxious/nervous/tense

1.9

76.5

1060

5525

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.7

75.8

438

1601

R31

ICD-10 Finland

Unspecified haematuria

1.7

75.8

1543

9009

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.8

75.7

172

341

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

75.7

465

1752

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.5

75.6

271

754

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

75.2

1765

10694

A07AA11

ATC

rifaximin; oral

9.9

75.1

AN4

Balloon angioplasty and drug eluding stent

2.7

74.9

429

1561

D07AC01

ATC

betamethasone; topical

1.4

74.7

4932

36934

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

74.6

510

2021

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

74.4

972

4967

K90

ICPC

Stroke/cerebrovascular accident

2.6

74.3

444

1651

D10

ICPC

Vomiting

2.3

74.2

591

2507

R4180

NOMESCO Finland

Podiatric therapy

4.0

74.1

215

517

E27.2

ICD-10 Finland

Addisonian crisis

27.6

73.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

73.7

785

3735

M48.0

ICD-10 Finland

Spinal stenosis

1.6

73.6

1894

11737

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

10.4

73.5

S22.3

ICD-10 Finland

Fracture of rib

1.9

73.5

1022

5330

C03BA11

ATC

indapamide; oral

2.5

73.3

497

1962

R10.0

ICD-10 Finland

Acute abdomen

2.5

73.3

467

1791

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

73.2

447

1679

3AC01, ,

NOMESCO Finland

4.5

73.2

181

385

N17

ICPC

Vertigo/dizziness

1.6

73.1

1735

10537

B82

ICPC

Anaemia other/unspecified

2.6

72.6

447

1686

A99

ICPC

Disease/condition unspecnature/site

1.7

72.6

1321

7474

WW200

NOMESCO Finland

Immunization

2.8

72.4

386

1354

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

72.3

1569

9312

U07

ICPC

Urine symptom/complaint other

1.8

72.3

1091

5839

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

72.2

637

2818

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

5.0

72.2

157

300

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

72.2

2744

18537

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.2

72.1

300

916

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

71.9

196

450

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

71.7

474

1850

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.4

71.7

536

2212

A10AD05

ATC

insulin aspart; parenteral

3.0

71.6

334

1090

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.4

71.5

183

400

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.7

71.3

232

605

L04AX01

ATC

azathioprine; systemic

2.2

71.3

601

2610

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

71.1

420

1552

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.5

71.1

118

174

D07AA02

ATC

hydrocortisone; topical

1.6

71.0

1753

10747

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

71.0

424

1576

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.4

70.9

261

739

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.2

70.8

294

897

C10AA04

ATC

fluvastatin; oral

1.8

70.8

1196

6622

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

+∞

70.6

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

5.2

70.5

146

267

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.6

70.4

135

230

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.4

70.3

142

254

K85

ICPC

Elevated blood pressure

1.5

70.3

2387

15740

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.8

70.3

130

214

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.3

70.2

278

824

E23.2

ICD-10 Finland

Diabetes insipidus

12.1

70.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

70.0

2372

15631

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

70.0

682

3138

X58

ICD-10 Finland

Exposure to other specified factors

1.6

69.9

1743

10710

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

69.8

1135

6211

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

69.6

1399

8132

R52.2

ICD-10 Finland

Other chronic pain

2.4

69.6

511

2092

101

Kela drug reimbursment

Anterior pituitary hypofunction

5.8

69.5

129

213

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

69.5

1279

7256

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

69.4

593

2589

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

69.4

421

1577

C08DB01

ATC

diltiazem; oral

1.9

69.2

880

4454

R60.1

ICD-10 Finland

Generalized oedema

5.1

69.1

148

279

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

10.1

69.1

SPAT1139

SPAT

Nutrition survey

2.3

68.9

521

2160

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

68.7

905

4635

SPAT1053

SPAT

Memory test

1.5

68.7

2434

16187

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

68.7

1222

6865

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

68.6

422

1591

R06AE07

ATC

cetirizine; oral

1.4

68.5

5602

43277

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

68.3

608

2699

N05AC02

ATC

thioridazine; oral

3.0

68.3

308

986

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

68.2

425

1612

L04AD01

ATC

ciclosporin; systemic

3.2

68.1

279

844

H02AB07

ATC

prednisone; oral

1.6

68.0

1946

12347

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.6

67.8

124

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.6

67.7

421

1596

F05.8

ICD-10 Finland

Other delirium

4.3

67.6

176

390

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

67.4

2543

17127

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

67.4

337

1143

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

67.0

378

1365

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

8.1

66.9

107

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

66.8

377

1362

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.2

66.7

591

2618

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

66.7

412

1557

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.1

66.4

185

432

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

66.4

2723

18640

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

66.1

766

3754

ZZA00

NOMESCO Finland

Split skin graft

2.4

66.1

475

1926

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

65.9

570

2501

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.7

65.9

367

1317

N06AB05

ATC

paroxetine; oral

2.0

65.9

742

3601

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

65.8

671

3140

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.8

65.8

204

515

F20

ICD-10 Finland

Schizophrenia

5.6

65.6

126

215

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.1

65.5

183

428

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.6

65.5

390

1447

78891

ICD-8 Finland

Other general symptoms, Hypokaliaemia

+∞

65.5

C03DB01

ATC

amiloride; oral

12.7

65.2

C10AC01

ATC

colestyramine; oral

2.5

65.1

413

1580

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.6

65.1

E16.19

ICD-10 Finland

Other specified hypoglycaemia

7.1

65.0

133

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

5.3

64.9

133

241

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.4

64.9

449

1789

Z2221

NOMESCO Finland

Medical doctor

1.4

64.9

3457

24830

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

16.0

64.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

64.8

1343

7863

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.7

64.5

355

1266

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.1

64.5

182

429

F32

ICD-10 Finland

Depressive episode

2.2

64.5

584

2610

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.5

64.5

231

643

C07AB03

ATC

atenolol; systemic

1.9

64.4

935

4939

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

64.2

358

1285

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

64.2

1004

5427

D09

ICPC

Nausea

2.3

63.9

516

2200

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

63.7

1136

6381

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.7

63.6

204

527

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

63.6

228

635

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

63.5

2016

13076

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

63.5

1604

9874

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.1

63.2

177

415

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

63.0

809

4107

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

62.9

722

3526

SPAT1247

SPAT

Outpatient detoxication and monitoring

6.7

62.9

101

144

A10BK03

ATC

empagliflozin; oral

1.7

62.7

1191

6810

Z93.2

ICD-10 Finland

Ileostomy status

6.9

62.5

136

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

62.3

1662

10362

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

62.2

460

1889

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

62.1

1294

7584

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.7

62.1

199

514

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

62.1

2258

15067

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.2

61.9

130

241

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

61.9

592

2703

F50.1

ICD-10 Finland

Atypical anorexia nervosa

9.4

61.9

ZXA10

NOMESCO Finland

Bilateral

1.5

61.8

2623

18046

N06AX12

ATC

bupropion; oral

2.1

61.8

649

3070

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.9

61.8

291

955

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

61.7

566

2542

C10AX09

ATC

ezetimibe; oral

1.6

61.5

1676

10500

N06AX05

ATC

trazodone; oral

2.7

61.4

342

1227

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

7.0

61.4

130

C09DA06

ATC

candesartan and diuretics; oral

1.8

61.4

1065

5934

XA400

NOMESCO Finland

EEG

5.4

61.4

124

222

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.3

61.3

105

160

U14

ICPC

Kidney symptom/complaint

3.2

61.3

253

769

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.8

61.2

187

467

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

61.2

738

3667

J01FA06

ATC

roxithromycin; oral

1.3

61.1

5294

41056

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.4

61.0

220

615

SPAT1227

SPAT

Substance abuse rehabilitation

5.6

61.0

118

203

ZXD35

NOMESCO Finland

Usual procedure

2.3

60.9

484

2050

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

60.5

396

1538

130

Kela drug reimbursment

Malignant tumour

1.7

60.4

1354

8085

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

60.3

393

1523

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

6.4

60.1

101

151

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

8.8

60.1

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

60.1

2631

18199

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.2

59.9

163

374

H3601, E113,

ICD-10 Finland

3.2

59.9

240

717

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.2

59.8

237

703

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

59.7

552

2487

RS220, ,

NOMESCO Finland

3.6

59.7

205

555

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

59.6

1419

8601

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.9

59.6

180

446

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.0

59.6

106

168

K85

ICD-10 Finland

Acute pancreatitis

2.9

59.6

280

918

B03XA01

ATC

erythropoietin; parenteral

3.9

59.4

175

426

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

59.2

1487

9131

N03AX11

ATC

topiramate; oral

2.9

59.2

286

952

S76

ICPC

Skin infection other

1.9

58.8

734

3689

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.0

58.8

641

3073

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

58.7

298

1019

Z00.8

ICD-10 Finland

Other general examinations

1.8

58.6

991

5478

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.2

58.6

159

364

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.4

58.5

415

1672

JFB00

NOMESCO Finland

Partial resection of small intestine

2.9

58.5

281

932

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.8

58.5

299

1026

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.2

58.5

242

737

N02BF01

ATC

gabapentin; oral

1.7

58.3

1033

5788

EBA30

NOMESCO Finland

Extraction of root of tooth

1.9

58.2

798

4136

J96.1

ICD-10 Finland

Chronic respiratory failure

2.5

58.1

384

1498

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

58.0

612

2899

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.2

58.0

115

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

57.9

303

1053

R13

ICD-10 Finland

Dysphagia

1.8

57.8

959

5272

D12

ICPC

Constipation

2.1

57.8

537

2424

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.4

57.7

214

609

N18

ICPC

Paralysis/weakness

2.7

57.7

310

1092

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

9.4

57.7

U08

ICPC

Urinary retention

2.6

57.7

333

1217

Z94.4

ICD-10 Finland

Liver transplant status

7.2

57.5

116

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

57.3

345

1288

JFF13

NOMESCO Finland

Terminal enterostomy

7.6

57.1

103

R4120

NOMESCO Finland

Occupational therapy

1.9

57.1

785

4073

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.7

56.8

305

1074

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.2

56.7

225

668

UJD02

NOMESCO Finland

Gastroscopy

1.9

56.5

701

3516

M10.0

ICD-10 Finland

Idiopathic gout

2.2

56.4

490

2153

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

56.4

549

2523

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

56.3

461

1977

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.0

56.2

653

3201

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.9

56.2

171

426

SPAT1281

SPAT

Other administrative function

1.7

56.2

1048

5955

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

4.9

56.1

125

244

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

56.1

5111

39804

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

56.0

961

5335

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

56.0

488

2148

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

56.0

522

2360

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.5

55.7

354

1356

K02.1

ICD-10 Finland

Caries of dentine

1.3

55.5

7117

58085

T68

ICD-10 Finland

Hypothermia

5.4

55.5

111

197

RD210, ,

NOMESCO Finland

3.1

55.4

236

731

P74

ICPC

Anxiety disorder/anxiety state

2.4

55.4

409

1678

N88

ICPC

Epilepsy

5.0

55.3

120

229

G40.89

ICD-10 Finland

Other epilepsy

6.1

55.2

152

K78

ICPC

Atrial fibrillation/flutter

1.7

55.1

1195

7068

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.2

55.1

223

670

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

55.1

831

4438

U02

ICPC

Urinary frequency/urgency

1.5

55.1

1860

12199

U71

ICPC

Cystitis/urinary infection other

1.8

55.0

876

4756

OAA67, ,

SPAT

0.4

55.0

367

7767

AA400

NOMESCO Finland

Electroconvulsive therapy

4.6

54.9

132

275

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

54.8

469

2048

PE1AT

NOMESCO Finland

Femoral artery PTA

3.4

54.6

205

588

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

54.6

340

1290

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9908

70292

1.93

322.53

5.5

2.9

82.80

49.80

u/l

77.47

9219

64221

(3021601) Nitrite [Presence] in Urine by Test strip

8407

56535

1.90

322.35

7.8

4.9

0.00

estimate

1.34

2131

10503

(3009261) Glucose [Presence] in Urine by Test strip

8481

57230

1.90

321.34

6.1

3.8

0.00

estimate

0.00

2057

10356

(3005719) IgG [Mass/volume] in Serum or Plasma

1983

7695

2.66

314.67

3.0

2.8

10.65

10.69

g/l

0.09

1805

7018

(3009508) Creatinine [Moles/volume] in Urine

5906

35622

1.93

313.64

4.1

3.0

5.96

7.41

mmol/l

136.61

4955

29322

(3020891) Body temperature

1473

4880

3.07

313.60

9.1

4.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

1334

4182

3.23

311.80

6.5

3.7

1.52

1.35

mmol/l

2.93

1300

4135

(3034860) Kappa light chains.free [Mass/volume] in Serum

1213

3588

3.41

311.41

2.8

3.2

117.81

61.32

mg/l

0.59

944

2862

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1212

3584

3.41

311.29

2.8

3.2

44.30

44.91

mg/l

0.05

937

2869

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1187

3464

3.45

311.25

2.8

3.1

3.83

5.16

ratio

0.21

252

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3159

10501

3.34

307.65

11.3

6.9

116.88

121.06

g/l

22.53

3094

10192

(36304419) Bacteria [Presence] in Urine

5884

31512

2.25

307.65

4.8

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1290

3805

3.43

307.65

4.0

2.8

0.32

0.35

u/ml

3.26

784

2159

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8197

49529

2.21

307.65

2.5

1.9

91.16

95.35

pmol/l

11.59

4699

25218

(3018010) Neutrophils/100 leukocytes in Blood

8724

52916

2.29

307.65

8.0

5.7

61.03

57.58

115.18

8255

48993

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7859

46799

2.20

307.65

3.0

2.1

76.04

79.56

nmol/l

20.38

7096

40949

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1907

5152

3.88

307.65

5.2

2.4

1.34

1.24

3.52

1902

5125

(3010421) pH of Blood

1236

2977

4.21

307.65

6.3

3.5

7.42

1.46

1102

2727

(3022948) Iron [Moles/volume] in Serum or Plasma

4932

17376

3.49

307.65

3.8

2.2

11.09

12.77

umol/l

47.13

4564

15949

(3021901) Oxygen saturation in Capillary blood

1033

1901

5.47

307.65

3.7

2.6

—

(3024928) Oxygen saturation in Venous blood

951

2072

4.59

307.65

4.3

2.9

—

(3016038) Potassium [Moles/volume] in Urine

1333

405

34.17

307.65

1.4

1.2

31.95

35.75

mmol/l

2.49

1154

329

(3002582) Erythrocytes [#/volume] in Urine

6783

35173

2.48

307.65

5.1

3.1

92.24

106.33

e6/l

0.28

5749

26871

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1325

2623

5.16

307.65

4.4

2.8

24.41

25.05

mmol/l

4.16

1294

2566

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4682

15982

3.55

307.65

3.8

2.2

2.20

2.31

g/l

28.07

4336

14582

(3009343) pH of Capillary blood

2596

6959

4.06

307.65

5.8

3.3

7.41

7.42

2.22

489

839

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2101

7123

3.09

307.65

13.1

7.5

1.42

1.38

0.97

2085

7079

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6461

17272

5.37

307.65

4.8

3.0

0.78

0.82

mmol/l

91.90

6114

15977

(3013650) Neutrophils [#/volume] in Blood by Automated count

10307

65457

2.47

307.65

12.9

8.8

4.73

4.13

e9/l

86.70

9236

56932

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2102

7104

3.10

307.65

13.2

7.6

0.67

0.69

0.66

2086

7064

(3019069) Monocytes/100 leukocytes in Blood

8800

52588

2.36

307.65

8.6

6.2

8.90

8.72

5.67

8333

48616

(3028626) Oxygen [Partial pressure] in Capillary blood

1217

2403

5.14

307.65

5.1

3.0

8.10

8.15

kpa

0.40

1192

2347

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

8179

53502

1.96

307.65

3.6

2.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

961

1060

9.13

307.65

1.5

1.3

537.72

289.18

pmol/l

1.38

763

918

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

11046

59503

3.62

307.65

13.7

5.6

1.19

1.22

mmol/l

145.77

9362

49741

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3200

10519

3.38

307.65

2.8

2.2

0.19

0.21

g/l

14.66

2904

9777

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4552

23683

2.17

307.65

2.1

1.7

1.57

1.34

mg/l

2.74

3704

18118

(3037467) Urinalysis macro (dipstick) panel - Urine

11477

80643

2.34

307.65

7.2

4.3

—

(3042936) Bacteria identified in Isolate by Culture

3760

15984

2.63

307.65

2.7

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

3127

13317

2.54

307.65

2.3

1.7

—

(3006504) Eosinophils/100 leukocytes in Blood

8753

52278

2.35

307.65

8.2

5.9

2.58

2.88

28.01

8272

48257

(3022217) INR in Platelet poor plasma by Coagulation assay

10419

56200

3.30

307.65

20.5

15.9

1.27

1.33

inr

3.59

3450

15848

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1743

4609

3.93

307.65

2.4

1.9

2.55

2.34

ug/l

0.23

1534

4019

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1063

2604

4.10

307.65

5.3

3.3

1.93

1.53

mg/l

28.39

969

2348

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7287

34447

2.90

307.65

3.0

2.0

285.72

215.00

u/l

3.61

6923

31933

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2146

7227

3.12

307.65

10.8

6.5

24.34

24.67

mmol/l

2.42

2065

6868

(3023368) Bacteria identified in Blood by Culture

7957

32071

3.78

307.65

6.3

4.0

—

(40767503) Oxygen content in Capillary blood by calculation

1123

2330

4.87

307.65

3.6

2.2

15.38

16.30

8.88

656

1115

(3011985) Renin [Units/volume] in Plasma

1078

1097

9.98

307.65

1.9

1.3

73.05

53.69

mu/l

0.96

936

968

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12617

90862

2.67

307.65

13.0

7.1

88.64

79.34

u/l

55.28

12116

84667

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2162

6552

3.49

307.65

1.7

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1897

5112

3.88

307.65

1.8

1.6

1.62

1.55

g/l

2.09

1656

4303

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1858

5761

3.35

307.65

12.3

7.8

24.08

24.38

mmol/l

2.21

1782

5536

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

7909

42110

2.60

307.65

5.2

3.1

—

0.53

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1776

4940

3.73

307.65

6.9

3.4

48.81

47.75

0.93

1758

4884

(3000991) Gas panel - Venous blood

3322

8900

4.24

307.65

12.0

6.9

—

(3002079) Sodium [Moles/time] in 24 hour Urine

475

301

15.46

307.65

1.3

1.2

164.69

158.15

mmol/24h

0.50

475

301

(3018095) Leukocytes [#/volume] in Urine

7337

40707

2.35

307.65

5.9

3.4

123.52

113.37

e6/l

0.31

5945

29009

(3020630) Protein [Mass/volume] in Serum or Plasma

2670

9724

2.95

307.65

2.7

2.5

64.68

66.58

g/l

24.52

2424

8687

(3026782) Osmolality of Urine

6489

22970

3.89

307.65

3.9

2.8

437.29

550.17

mosm/kgh2o

316.27

5725

19529

(3004119) Hemoglobin [Mass/volume] in Venous blood

2370

6524

3.90

307.65

5.7

2.9

122.42

128.47

g/l

29.95

2318

6365

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3900

12927

3.50

307.65

10.2

6.2

4.94

5.09

kpa

14.08

3727

12292

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3595

13339

3.03

307.65

3.7

4.2

248.57

247.88

u/l

0.07

3356

12550

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2618

7057

4.04

307.65

5.9

3.3

5.11

5.17

kpa

2.53

2510

6615

(3023520) Reticulocytes [#/volume] in Blood

3009

10026

3.30

307.65

2.9

2.5

72.28

68.16

e9/l

6.49

2359

7673

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2409

6421

4.04

307.65

10.0

6.2

24.47

24.86

mmol/l

3.68

2374

6359

(3000850) Epithelial cells [#/volume] in Urine

5159

24915

2.45

307.65

4.0

2.4

5.91

5.39

e6/l

1.93

4817

22123

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10774

60496

3.24

307.65

9.4

6.0

11.95

11.80

umol/l

0.38

10311

57129

(3004588) Protein electrophoresis panel - Serum or Plasma

2149

8036

2.79

307.65

2.4

2.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

5724

28046

2.49

307.65

1.9

1.5

19.85

20.69

nmol/l

3.42

5060

23463

(3019060) Gas panel - Arterial blood

2369

7787

3.24

307.65

6.9

4.4

—

(3019198) Lymphocytes [#/volume] in Blood

9423

57497

2.41

307.65

8.0

5.7

1.74

1.92

e9/l

9.28

8459

50504

(3024354) Oxygen [Partial pressure] in Venous blood

3203

8214

4.41

307.65

5.8

2.8

4.62

4.49

kpa

2.28

3075

7945

(3026008) Bacteria identified in Urine by Culture

7551

37657

2.76

307.65

4.7

3.2

—

(3012544) pH of Venous blood

4030

10236

4.70

307.65

6.7

3.3

7.37

7.38

0.40

(3003396) Base excess in Arterial blood by calculation

3919

12863

3.54

307.65

10.1

6.2

1.23

1.12

mmol/l

0.64

3145

10201

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3564

12633

3.18

307.65

2.3

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

6198

32508

2.35

307.65

4.9

3.0

0.57

0.45

e6/l

2.94

5227

24839

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8163

44962

2.53

307.65

4.3

2.6

186.28

144.82

ug/l

13.94

7494

40764

(3003181) Sodium [Moles/volume] in Urine

3431

1137

36.53

307.65

1.6

1.2

57.98

68.94

mmol/l

12.21

2711

871

(3018418) pH of Serum or Plasma

7059

34664

2.71

307.65

7.2

3.5

7.40

0.17

1805

6610

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5152

13564

4.90

307.65

9.2

4.6

1.07

1.03

mmol/l

15.25

4859

12406

(3027315) Oxygen [Partial pressure] in Blood

1110

2595

4.31

307.65

6.1

3.7

8.44

8.51

kpa

0.58

1077

2534

(3016502) Oxygen saturation in Arterial blood

3542

11492

3.50

307.65

10.6

6.6

95.20

95.60

2.77

3429

11045

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2194

4842

4.86

307.65

6.9

3.7

24.05

24.21

mmol/l

1.06

2127

4731

(3022313) Gas panel - Capillary blood

1673

5180

3.32

307.65

6.4

3.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2515

6732

4.05

307.65

5.8

3.3

2.05

1.89

mmol/l

0.92

1912

5041

(3020779) Urea [Moles/volume] in Serum or Plasma

3742

9260

4.74

307.65

11.2

5.7

11.68

9.89

mmol/l

29.44

3572

8721

(3023183) Ammonium ion [Moles/volume] in Plasma

1465

2041

7.44

307.65

3.3

2.5

34.38

34.78

umol/l

0.16

1338

1807

(3027801) Oxygen [Partial pressure] in Arterial blood

3898

12922

3.49

307.65

10.1

6.2

11.48

12.34

kpa

21.00

3717

12275

(3035350) Ketones [Presence] in Urine by Test strip

8460

56545

1.93

307.65

6.0

3.7

0.00

estimate

3.19

2217

11336

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2832

12260

2.46

307.65

3.8

2.6

10.44

9.49

umol/l

1.04

2450

10647

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2765

12313

2.38

307.65

5.9

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2560

10646

2.54

307.65

2.5

1.7

1.84

1.48

48.37

2120

9192

(3028271) Lactate [Moles/volume] in Capillary blood

876

1788

4.88

307.65

2.7

1.7

1.73

1.72

mmol/l

0.10

859

1742

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4349

21986

2.22

307.65

5.8

3.4

287.28

501.02

ng/l

2.44

3742

17728

(3019309) Folate [Moles/volume] in Red Blood Cells

5202

24159

2.57

307.65

2.1

1.7

1305.97

1165.54

nmol/l

16.76

4009

17841

(3031040) Bacteria [#/volume] in Urine by Automated count

11584

78203

2.59

307.65

7.8

4.5

1360.01

1672.60

e6/l

0.31

234

1003

(3022096) Basophils/100 leukocytes in Blood

8527

50618

2.33

307.65

8.1

5.9

0.61

0.67

21.21

8055

46651

(3001604) Monocytes [#/volume] in Blood

9292

55970

2.43

307.65

7.8

5.6

0.66

0.60

e9/l

35.89

8229

48063

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1511

3170

4.92

307.65

1.5

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7487

36221

2.86

307.65

4.1

2.4

60.52

64.96

u/l

0.55

7039

33093

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7186

35627

2.70

307.65

4.2

2.8

2602.24

1431.65

ng/l

42.49

6377

30348

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

10227

54135

3.31

307.65

12.5

5.1

1.19

1.21

mmol/l

163.07

9613

48467

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8499

45456

2.71

307.65

6.3

3.4

79.77

61.95

ng/l

0.48

7114

32726

(3002030) Lymphocytes/100 leukocytes in Blood

8881

53815

2.32

307.65

8.4

6.0

23.44

27.30

179.45

8402

49886

(3014111) Lactate [Moles/volume] in Serum or Plasma

3412

9476

4.11

307.65

9.7

5.8

1.47

1.37

mmol/l

3.37

3313

9194

(3024561) Albumin [Mass/volume] in Serum or Plasma

9841

50876

3.27

307.65

8.0

4.4

32.92

35.17

g/l

229.32

9263

46754

(3044640) Blood type and Crossmatch panel - Blood

6287

36385

2.08

307.65

3.6

2.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

9003

52532

2.49

307.65

8.8

6.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1688

5818

2.98

307.65

13.6

8.6

—

(3013115) Eosinophils [#/volume] in Blood

9490

57980

2.42

307.65

8.2

5.8

0.19

0.20

e9/l

5.40

8467

50468

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1853

5066

3.82

307.65

5.3

2.4

0.68

0.65

2.93

1848

5041

(3033658) Prothrombin time (PT) actual/Normal

5036

28303

2.02

307.65

7.0

3.7

84.86

87.80

11.76

4905

27587

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3965

9886

4.78

307.65

6.8

3.3

5.77

5.84

kpa

3.64

3827

9591

(3015377) Calcium [Moles/volume] in Serum or Plasma

6998

40561

2.16

307.65

4.2

3.3

2.33

2.36

mmol/l

46.25

6158

35026

(3035637) Corticotropin [Mass/volume] in Plasma

796

1103

7.19

307.65

1.5

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

509

670

7.44

307.65

1.9

1.3

1.33

1.40

promille

0.33

394

515

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6834

29020

3.21

307.65

2.9

2.2

3.17

3.08

mg/l

2.13

5935

24518

(3027273) Bicarbonate [Moles/volume] in Venous blood

1964

5309

3.88

307.65

6.4

2.8

25.00

25.32

mmol/l

2.65

1907

5166

(3027945) Reticulocytes/100 erythrocytes in Blood

3798

13255

3.28

307.65

2.8

2.3

1.98

1.75

27.36

3362

11572

(3014007) Fractional oxyhemoglobin in Arterial blood

2110

7163

3.09

307.65

13.2

7.6

93.42

93.90

2.47

2092

7140

(3013290) Carbon dioxide [Partial pressure] in Blood

1106

2579

4.32

307.65

6.1

3.7

4.99

5.00

kpa

0.18

1073

2518

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2926

8098

4.00

307.65

2.0

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1526

3795

4.13

307.65

2.4

2.2

575.40

569.18

ug/l

0.02

1449

3551

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5165

18840

3.41

307.65

2.3

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3580

12609

3.21

307.65

2.2

1.7

—

(3008295) Osmolality of Serum or Plasma

1484

742

20.94

307.65

1.5

1.4

268.19

285.43

mosm/kgh2o

65.24

1185

535

(3012501) Base excess in Blood by calculation

1105

2578

4.32

307.65

6.1

3.6

3.10

2.58

mmol/l

4.97

809

1750

(3002032) Base excess in Venous blood by calculation

3953

9846

4.78

307.65

6.9

3.3

2.05

1.98

mmol/l

0.37

3369

8321

(3006315) Basophils [#/volume] in Blood

9332

56147

2.45

307.65

7.8

5.6

0.04

e9/l

0.18

8256

48198

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6354

34026

2.31

307.65

4.5

3.1

42.01

35.05

u/l

1.88

6001

31967

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1984

6727

3.07

307.65

2.0

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4466

14992

3.57

307.65

3.9

2.2

20.71

22.33

10.26

3834

12555

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4683

8458

7.10

307.65

2.3

401.84

369.04

nmol/l

14.13

4320

7728

(3013826) Glucose [Moles/volume] in Serum or Plasma

11503

67987

3.31

307.65

9.9

4.1

7.12

6.71

mmol/l

58.22

11162

63466

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4121

16531

2.87

307.65

2.6

2.0

30.32

29.89

3.33

3996

15996

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2534

7992

3.41

307.65

5.6

3.2

120.47

86.85

ng/l

25.19

2164

6721

(1616796) Gas panel - Central venous blood

1234

2322

5.41

307.65

5.0

3.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

5947

36137

1.92

307.18

4.7

3.5

25.94

6.84

mg/mmol

9.80

4048

21900

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4651

26248

1.98

297.13

1.9

1.7

19926701.78

32707313.04

pmol/l

1.01

3794

21124

(3028026) IgM [Mass/volume] in Serum or Plasma

1628

5916

2.81

292.41

1.9

2.0

1.30

1.47

g/l

1.79

1468

5333

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2390

10520

2.37

288.43

3.2

2.2

6.16

7.07

ug/l

1.37

1997

9034

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2308

10003

2.40

288.42

7.2

3.2

1.21

1.23

mmol/l

24.26

2127

8502

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3483

17920

2.09

286.08

4.3

2.8

3.07

2.66

e6/l

1.15

2128

9766

(3022806) Fractional oxyhemoglobin in Capillary blood

691

1446

4.71

285.98

2.5

1.7

88.80

89.51

1.90

677

1423

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4847

28069

1.93

284.69

3.5

2.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1343

4476

3.03

281.95

7.3

4.7

1.68

1.65

0.50

1276

4170

(3006184) Hemoglobin [Mass/volume] in Capillary blood

937

2493

3.74

281.82

3.0

2.1

123.21

129.03

g/l

8.87

793

1745

(3012516) Albumin [Mass/volume] in Urine

5628

34339

1.88

280.76

4.1

3.1

552.42

399.37

mg/l

1.50

3942

21168

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1359

4609

2.98

276.48

7.2

3.6

24.80

24.98

mmol/l

0.95

1265

4205

(3015736) pH of Urine

6918

45231

1.82

274.28

5.3

3.5

6.08

5.83

3.61

213

2683

(3017181) Myelocytes/100 leukocytes in Blood

2216

9649

2.38

273.00

4.7

3.9

0.94

0.96

0.18

1064

3320

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3694

19747

2.02

271.42

4.0

2.7

1.37

1.32

e6/l

0.11

2322

11495

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

958

2667

3.58

269.21

1.7

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2236

9934

2.33

262.36

4.0

2.3

35.43

53.68

u/l

1.29

1897

8482

(3017143) Hepatitis C virus Ab [Presence] in Serum

2213

9798

2.34

261.69

2.0

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

954

2706

3.51

260.40

2.9

3.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

794

1998

3.93

258.20

7.1

4.5

839.86

1460.37

iu/ml

0.34

134

279

(3007930) Methemoglobin/Hemoglobin.total in Blood

1284

4418

2.93

253.85

7.4

4.7

0.88

0.89

0.26

1219

4111

(40758558) Short blood count panel - Blood

4807

28640

1.86

252.62

9.7

6.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

915

2594

3.51

249.77

1.8

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

2074

9159

2.33

245.68

4.8

3.9

0.12

0.10

0.69

923

2856

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

942

2754

3.40

245.04

1.5

1.6

—

(3021589) Normoblasts [#/volume] in Blood

7329

49873

1.75

243.82

18.8

9.2

0.00

e9/l

0.64

6246

40913

(3026493) Urate [Moles/volume] in Serum or Plasma

4930

29901

1.83

242.66

3.7

2.5

3129.04

5058.93

umol/l

3.13

4249

25597

(3009466) Valproate [Moles/volume] in Serum or Plasma

627

1396

4.41

239.85

5.7

4.4

372.31

356.12

umol/l

1.76

551

1156

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1028

3256

3.15

234.45

1.5

1.4

234.51

273.13

ug/g

7.01

644

1913

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1043

3364

3.09

230.54

2.2

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11161

86325

1.81

230.02

5.0

3.8

15.41

14.92

pmol/l

60.54

10198

76793

(3026250) Tacrolimus [Mass/volume] in Blood

288

309

9.02

227.61

41.6

30.7

7.22

7.21

ug/l

0.02

262

272

(3002179) Metamyelocytes/100 leukocytes in Blood

1975

8813

2.30

227.23

4.5

3.8

0.68

0.69

0.07

914

2866

(3013707) Erythrocyte sedimentation rate by Westergren method

11094

85984

1.79

222.85

5.7

4.1

19.01

12.90

mm/h

190.74

10296

78357

(3019230) Fractional oxyhemoglobin in Venous blood

694

1763

3.88

222.30

4.5

2.7

62.53

63.89

0.75

685

1756

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2182

10267

2.19

220.25

4.1

2.8

315.24

217.49

ng/l

10.16

2021

9349

(3000012) Reticulocyte production index

676

1699

3.91

219.78

2.0

2.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3939

22971

1.85

215.48

3.6

3.1

2.47

2.46

mmol/l

2.71

3439

20093

(3043409) Potassium [Moles/volume] in Arterial blood

1074

3660

2.93

215.10

7.4

3.9

3.89

3.88

mmol/l

0.13

1064

3636

(3047181) Lactate [Moles/volume] in Blood

1029

3438

2.98

213.48

8.0

5.5

1.44

1.31

mmol/l

2.38

920

3020

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2336

11428

2.11

212.84

2.0

1.5

—

(3025159) Blasts/100 leukocytes in Blood

1906

8622

2.26

211.36

4.8

3.9

0.23

0.41

0.60

762

2374

(3007164) IgA [Mass/volume] in Serum or Plasma

3415

19136

1.89

211.23

1.7

1.4

2.93

2.53

g/l

12.60

2180

11008

(3029937) Albumin [Presence] in Urine by Test strip

5040

31886

1.75

207.94

6.7

4.1

0.00

estimate

0.95

1961

10135

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

570

1331

4.19

204.70

1.2

1.3

0.94

1.84

nmol/l

0.45

539

1275

(46235355) HIV 1 and 2 tests - Meaningful Use set

2572

13225

2.02

204.03

2.1

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

569

1331

4.19

203.86

1.2

1.3

0.30

0.26

nmol/l

0.13

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1240

4731

2.62

199.70

1.4

1.6

8.74

17.23

u/ml

1.59

131

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6471

44167

1.67

199.52

6.6

4.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

714

1990

3.53

199.39

1.8

1.6

—

(3013512) EKG study

5536

36369

1.70

196.48

5.8

3.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13729

115315

2.10

196.32

36.4

13.8

26.40

25.26

mg/l

4.14

12753

91244

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

142

23.93

192.44

1.2

1.5

13.94

20.10

pmol/l

0.30

116

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

599

1530

3.84

190.10

1.7

1.4

—

(3025941) Bacteria identified in Stool by Culture

1399

5798

2.42

188.82

1.5

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

592

1512

3.84

187.88

4.0

2.5

17207.35

7096.06

u/ml

0.29

102

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

582

1477

3.86

186.38

7.1

6.0

12.73

11.78

mg/l

4.46

532

1341

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

517

1223

4.13

182.35

1.2

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

2579

13770

1.94

181.57

1.4

1.3

522.53

550.22

titre

0.31

553

3047

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

646

1799

3.52

180.43

5.5

2.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

502

1179

4.16

178.75

1.3

—

nmol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

815

2638

3.05

178.17

1.3

1.2

122.39

159.62

titre

0.45

209

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1382

5842

2.37

178.06

4.2

2.5

0.34

0.29

e6/l

0.64

1343

5699

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1136

4390

2.58

177.62

2.5

2.2

7.62

7.39

g/l

3.92

1016

3869

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1135

4387

2.58

177.39

2.5

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1133

4379

2.58

177.09

2.5

2.2

3.68

3.70

g/l

0.10

1013

3860

(3037756) Immunofixation for Serum or Plasma

770

2429

3.12

175.91

1.5

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

671

1955

3.37

174.64

1.7

1.4

—

(40768797) Stomach Pathology biopsy report

2802

15592

1.87

172.98

1.4

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

803

2628

3.01

172.10

1.2

1337.06

948.31

titre

0.54

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1255

5183

2.42

170.07

2.4

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1173

4718

2.48

168.34

2.3

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

608

1705

3.49

167.91

1.6

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

271

388

6.75

167.73

2.2

2.0

115.42

122.52

umol/l

0.12

146

209

(3040151) Glucose [Moles/volume] in Capillary blood

495

1207

4.00

167.48

8.5

10.9

7.45

7.39

mmol/l

0.10

441

975

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

832

2874

2.86

161.61

3.1

2.5

3.66

3.57

g/l

0.76

791

2732

(3042733) HLA Ab [Presence] in Serum

209

233

8.64

160.28

5.1

4.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1073

4234

2.52

160.18

2.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2438

13272

1.89

159.97

3.8

4.1

28.80

23.97

ug/l

0.15

2067

10922

(3041096) Erythrocytes [Presence] in Urine by Automated

4546

29573

1.65

159.96

5.8

3.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1051

4121

2.53

158.97

2.5

2.2

3.08

2.97

g/l

2.31

930

3603

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1049

4125

2.52

157.68

2.5

2.2

10.16

10.46

g/l

0.97

921

3583

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

550

1507

3.57

157.27

1.9

2.1

32.56

32.52

0.06

544

1497

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3621

22273

1.71

157.08

1.4

1.2

1.81

1.79

u/ml

0.03

932

5774

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

730

2399

2.99

155.09

1.6

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

546

1514

3.52

153.30

1.6

1.4

—

(3037121) Protein [Mass/volume] in Urine

1002

3909

2.54

153.04

3.9

2.8

0.44

0.28

g/l

4.11

542

1502

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

610

1831

3.26

151.12

2.0

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

450

1113

3.93

149.21

2.6

2.3

1.38

1.03

g/24h

1.70

252

484

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

552

1575

3.42

148.26

1.6

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12590

105232

1.72

147.81

6.2

4.5

1.98

2.12

mu/l

1.88

11645

94189

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

591

1767

3.27

147.32

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

591

1767

3.27

147.32

1.7

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1306

5838

2.23

146.51

3.1

3.0

4.12

4.43

pmol/l

19.52

1135

5116

(40768446) Kidney Pathology biopsy report

220

291

7.29

146.31

2.2

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

241

354

6.57

145.60

1.7

1.5

7.79

11.18

nmol/l

0.20

201

285

(40761536) Microorganisms panel - Urine sediment

1921

9951

1.96

145.32

6.9

3.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

403

938

4.17

145.10

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

600

1847

3.18

142.51

2.0

1.3

18.10

18.65

u/ml

0.03

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

556

1645

3.30

140.93

2.0

1.3

113.52

121.19

u/ml

0.65

145

359

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

938

3694

2.51

140.17

1.6

233.85

247.86

titre

0.05

182

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

546

1609

3.31

139.27

1.6

1.2

280.00

282.29

u/ml

0.06

353

992

(44816559) Phosphatidylethanol [Mass/volume] in Blood

539

1580

3.33

138.65

1.7

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

569

1733

3.21

137.52

1.6

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4135

27121

1.61

136.56

5.5

3.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

723

2537

2.80

136.03

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

723

2537

2.80

136.03

1.5

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

467

1269

3.58

135.10

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

924

3730

2.44

130.73

2.6

2.3

0.83

1.14

g/l

1.14

780

3112

(3036489) Thrombin time

902

3603

2.47

130.57

2.5

2.0

22.07

21.72

0.61

828

3138

(3003434) Protein [Mass/volume] in Pleural fluid

548

1687

3.17

130.05

1.5

1.4

29.45

33.12

g/l

7.66

486

1511

(3011648) Oxygen content in Venous blood

330

722

4.42

128.71

3.6

2.7

10.37

10.90

1.34

330

722

(3019977) pH of Arterial blood

289

576

4.85

126.33

2.8

2.4

7.41

7.42

0.65

235

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

376

922

3.95

126.10

1.7

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

630

2141

2.88

125.70

1.4

1.3

4.08

3.74

mmol/l

8.41

588

2007

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

772

2930

2.59

124.33

1.7

1.6

0.23

g/l

0.52

726

2763

(3028707) Methadone [Presence] in Urine by Screen method

366

894

3.97

123.41

3.2

2.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

705

2567

2.69

123.38

1.6

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

584

1924

2.96

123.23

3.4

1.57

1.56

0.01

529

1689

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

788

3034

2.55

123.18

1.7

1.6

1.14

1.16

g/l

1.55

746

2873

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

327

741

4.27

121.91

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

229

390

5.66

119.32

2.6

1.9

1100.47

1937.32

e6/l

0.28

172

274

(3010375) cycloSPORINE [Mass/volume] in Blood

228

387

5.68

119.22

30.3

25.9

107.87

113.44

ug/l

0.59

182

337

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

681

2479

2.69

119.19

1.5

1.4

610.80

552.53

mg/l

0.58

647

2346

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

113

10.95

117.75

5.1

4.9

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

759

2933

2.54

117.67

2.8

2.3

88.10

90.27

1.50

736

2813

(3044242) Glucose [Moles/volume] in Arterial blood

252

476

5.11

117.23

2.3

1.9

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

234

414

5.45

117.06

16.2

16.3

1491.55

1390.49

nmol/l

0.92

223

401

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

317

725

4.23

116.77

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

843

3439

2.41

116.28

2.4

2.1

35.73

37.57

g/l

12.41

720

2912

(3039000) Anion gap in Blood

668

2441

2.68

116.00

10.0

6.4

11.87

11.10

mmol/l

4.59

619

2166

(3018572) Chloride [Moles/volume] in Blood

668

2442

2.68

115.90

10.0

6.4

101.66

105.30

mmol/l

27.55

619

2167

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

800

3204

2.45

114.88

2.5

2.2

0.04

0.03

g/l

0.30

729

2892

(3048929) Epstein Barr virus Ab [Presence] in Serum

661

2417

2.67

114.62

1.5

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

13893

121399

1.81

113.99

47.1

15.7

136.93

139.74

mmol/l

307.65

13672

117763

(3012565) Volume of 24 hour Urine

248

474

5.05

113.83

2.0

2.1

1932.56

1917.19

0.07

213

403

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

609

2144

2.77

113.65

1.2

89.09

155.93

titre

0.61

(3000494) Fungus identified in Specimen by Culture

2254

13178

1.73

113.20

1.7

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

532

1750

2.96

112.49

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7875

61038

1.46

112.11

3.1

2.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

764

3034

2.47

111.70

1.4

1.5

15.98

15.67

iu/ml

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

602

2133

2.75

110.95

1.5

593.26

2439.87

e6/l

1.12

524

1774

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

222

396

5.40

110.08

11.4

11.7

803.45

834.29

nmol/l

0.32

213

375

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

600

2132

2.75

109.97

1.5

35.99

29.06

e6/l

0.13

491

1696

(3023103) Potassium [Moles/volume] in Serum or Plasma

13897

121707

1.79

109.37

47.0

15.9

3.98

mmol/l

0.44

13665

117836

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

693

2657

2.55

109.11

2.8

2.5

221.25

194.32

9.33

662

2517

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1292

6420

2.00

108.58

1.6

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

606

2184

2.71

108.06

1.5

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

567

1975

2.80

107.92

1.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

203

340

5.75

107.65

2.5

1.7

9369.85

12104.75

e6/l

0.18

119

196

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

406

1171

3.36

107.05

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

406

1171

3.36

107.05

1.7

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

376

1038

3.51

106.13

1.3

1.2

—

36.44

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

179

270

6.37

105.45

1.7

1.4

12.54

13.62

g/l

0.69

138

205

(3008037) Lactate [Moles/volume] in Venous blood

647

2455

2.57

104.02

5.3

2.9

1.62

1.63

mmol/l

0.06

635

2399

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

318

794

3.87

103.98

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

277

628

4.26

103.21

2.4

2.2

17.29

17.42

nmol/l

0.07

256

596

(3023199) Leukocytes [#/volume] in Pleural fluid

469

1509

3.02

103.08

1.6

1.4

5631.19

2347.37

e6/l

0.79

356

1099

(3027456) Digoxin [Moles/volume] in Serum or Plasma

691

2734

2.47

101.70

3.5

3.1

0.88

0.80

nmol/l

2.55

514

2116

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

322

824

3.78

101.68

2.3

2.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

738

3010

2.40

101.63

2.6

2.2

0.00

g/l

0.62

669

2708

(21494890) Protein electrophoresis panel - 24 hour Urine

381

1101

3.35

100.15

2.1

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

157

218

6.92

99.99

1.3

1.2

405.27

259.71

pmol/l

2.13

159

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

725

2960

2.40

99.59

2.6

2.2

0.00

g/l

-0.00

667

2699

(3036782) Glucose [Moles/volume] in Pleural fluid

376

1092

3.33

98.05

1.3

6.82

6.18

mmol/l

3.66

350

1001

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

209

392

5.13

98.04

3.1

2.8

—

(3030313) Adrenal Ab [Titer] in Serum

18.67

97.97

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

798

3423

2.29

97.84

4.7

3.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

371

1074

3.34

97.24

3.3

2.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

352

988

3.45

96.85

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

352

988

3.45

96.85

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

352

988

3.45

96.85

1.7

1.6

—

(3044007) Cell count panel - Peritoneal fluid

180

300

5.77

95.96

2.5

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

530

1896

2.72

95.79

3.4

1.6

0.92

0.80

nmol/l

1.87

435

1578

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

391

1182

3.20

95.53

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

388

1169

3.22

95.32

1.2

64.59

62.49

u/l

0.19

358

1029

(3033799) Differential panel - Peritoneal fluid

191

339

5.42

95.25

2.3

1.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

229

478

4.61

94.73

2.5

2.2

94.79

96.22

0.20

223

454

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

658

2644

2.43

93.56

2.4

2.2

192.77

85.26

ug/min

4.93

400

1467

(40757494) Bilirubin.total [Moles/volume] in Blood

266

632

4.06

93.15

3.2

2.0

20.79

33.67

umol/l

0.77

(3024932) HLA-DR beta [Type]

165

260

6.10

93.14

1.1

—

(3017569) Oxygen content in Arterial blood

235

508

4.46

93.08

2.2

—

(3019150) Specific gravity of Urine by Refractometry

3713

25538

1.50

92.66

6.4

4.3

1.01

1.02

kg/l

8.92

559

3865

(3024471) HLA-A [Type]

168

271

5.96

92.63

1.0

—

(3036180) Methadone [Presence] in Urine

162

254

6.13

91.91

2.7

2.5

—

(40761535) Cells panel - Urine sediment

1828

10645

1.72

91.68

5.1

3.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

435

1435

2.94

91.44

1.6

1.4

—

(3019225) pH of Specimen

2147

13079

1.65

90.77

8.2

3.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

489

1726

2.75

90.68

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

436

1447

2.92

90.66

1.6

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

141

194

6.97

90.57

1.4

1.2

167.04

52.29

mu/l

1.24

100

144

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

442

1482

2.89

90.22

1.6

1.4

—

(3044889) 12 lead EKG panel

9960

82271

1.42

90.19

5.5

3.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

440

1475

2.89

89.84

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

424

1393

2.95

89.78

1.6

1.4

52872.79

52072.82

e6/l

0.02

269

832

(3048689) Calprotectin [Mass/mass] in Stool

2001

12018

1.67

89.26

2.3

2.2

206.82

142.07

ug/g

7.14

1596

9336

(3042631) Mycobacterium sp identified in Specimen

491

1752

2.72

89.16

2.5

2.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

203

405

4.82

88.68

2.6

2.2

57.46

51.98

umol/l

1.16

170

334

(3036603) Volume of Urine

245

572

4.13

87.85

1.6

2047.45

1800.35

3.23

234

549

(3012441) Differential panel - Pleural fluid

402

1298

3.00

87.78

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

408

1330

2.97

87.60

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

236

541

4.20

86.70

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

236

541

4.20

86.70

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

164

276

5.71

86.58

3.2

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

164

276

5.71

86.58

3.2

2.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

425

1430

2.88

86.18

1.6

1.4

—

(3045716) Anion gap in Serum or Plasma

215

461

4.49

86.05

3.1

2.2

9.65

9.55

mmol/l

0.11

208

453

(3005988) Vibrio sp identified in Specimen by Organism specific culture

425

1433

2.87

85.85

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

424

1432

2.87

85.39

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

359

1107

3.14

84.85

1.8

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

280

738

3.66

84.73

1.4

1.3

2.41

2.19

mmol/l

0.88

262

684

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

25.35

84.32

1.1

1.2

227.55

192.50

pmol/l

0.15

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

229

525

4.20

84.13

1.4

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

363

1139

3.08

83.30

1.3

561.50

499.76

u/l

0.14

348

1085

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

437

1532

2.77

82.07

2.4

2.7

163.88

1205.07

u/ml

1.00

425

1517

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

604

2476

2.38

82.05

1.6

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

579

2337

2.41

81.42

5.6

3.0

7.78

7.58

mmol/l

0.81

569

2288

(4035726) Immunohistochemistry procedure

1787

10698

1.67

80.12

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

254

651

3.76

80.06

1.8

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

180

356

4.86

79.47

2.9

2.7

30.06

28.31

umol/l

0.92

128

267

(3045788) Cell count panel - Pleural fluid

358

1146

3.02

79.36

1.6

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

271

736

3.55

78.44

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

251

650

3.72

77.95

1.8

1.5

—

(3023419) Bacteria identified in Sputum by Culture

483

1838

2.55

77.05

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

117

8.35

76.52

9.8

5.84

5.40

mmol/l

0.43

102

117

(3014765) Yersinia sp identified in Stool by Organism specific culture

689

3089

2.18

75.59

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

690

3099

2.17

75.35

1.4

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

145

249

5.59

74.97

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1613

9565

1.68

74.69

4.1

2.5

52.94

64.49

ml/min/173m2

21.51

797

3749

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

279

800

3.36

74.27

1.3

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

422

1534

2.66

73.86

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

680

3063

2.16

73.70

1.4

1.2

—

(3044927) Protein electrophoresis panel - Urine

359

1204

2.88

73.24

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

215

522

3.96

73.16

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

432

1598

2.62

73.02

3.1

2.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

422

4.33

72.77

4.4

4.2

1043.85

1179.36

mg/l

0.04

141

289

(3010838) Calcium [Moles/time] in 24 hour Urine

447

1685

2.57

72.70

1.8

1.7

3.95

4.98

mmol/24h

8.68

378

1455

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

385

1346

2.77

72.68

1.1

1.66

1.52

g/l

6.66

341

1208

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

147

267

5.28

71.54

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

119

176

6.48

71.51

1.6

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12309

107196

1.44

71.16

8.2

5.6

42.45

39.75

mmol/mol

116.40

11322

97132

(3011288) Drugs identified in Urine by Screen method

386

1368

2.73

70.99

4.1

2.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

870

4350

1.96

70.98

3.1

3.5

1254.07

1422.06

u/ml

0.12

743

3699

(3004451) EKG impression Narrative

206

499

3.97

70.33

1.5

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

429

1616

2.57

69.87

1.4

1.6

0.69

0.84

g/l

1.73

308

1205

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

505

3.92

69.19

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

327

1087

2.90

67.80

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

860

4354

1.93

67.57

1.8

39.46

39.50

u/l

0.02

740

3801

(3008757) Leukocyte morphology finding [Identifier] in Blood

375

1355

2.68

66.42

3.5

3.9

—

(3035880) pH of Pleural fluid

236

655

3.47

66.13

1.2

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

168

366

4.41

65.98

3.1

1.5

2.01

1.94

umol/l

0.34

157

343

(21494755) Public health laboratory ask at order entry panel

307

7509

0.38

65.62

1.3

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

186

442

4.04

65.21

1.3

62.17

65.11

0.14

(3016879) Cocaine [Presence] in Urine

471

1924

2.37

64.43

3.2

2.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

411

1585

2.51

63.74

2.1

1.8

24.16

24.15

ug/l

0.00

395

1546

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

260

5.05

63.51

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

14.58

62.90

3.6

2.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

252

754

3.22

62.68

1.3

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

131

244

5.15

62.04

1.5

1.3

23.24

56.17

g/l

0.74

189

(40762365) Oxygen content in Arterial blood by calculation

113

184

5.88

61.80

2.7

2.4

14.60

14.96

ml/dl

0.58

174

(40761511) CBC panel - Blood by Automated count

13410

119460

1.48

61.69

33.8

13.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

32.61

61.24

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

490

2083

2.28

61.13

3.2

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

236

690

3.29

60.96

1.1

1.0

296.50

290.79

mg/l

0.35

207

612

(3017354) Segmented neutrophils/100 leukocytes in Blood

345

1254

2.66

60.41

3.2

3.6

61.71

57.10

3.24

295

1058

(3016018) Differential panel - Cerebral spinal fluid

296

993

2.87

60.39

1.7

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

506

2196

2.23

60.07

2.1

1.6

393.72

284.12

mu/l

5.45

469

2007

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

281

919

2.95

60.03

1.2

1.3

11.41

13.48

u/l

0.59

253

848

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

581

2675

2.11

59.42

2.9

3.3

735.12

628.93

u/ml

0.14

525

2417

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

240

724

3.19

58.92

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

487

2100

2.25

58.71

3.3

2.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

167

400

4.01

57.97

3.0

1.5

26.08

29.19

umol/l

2.72

160

386

(3027008) Opiates [Presence] in Urine

484

2095

2.24

57.82

3.2

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

355

7737

0.42

57.44

1.7

1.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13728

123234

1.50

56.92

42.1

16.2

90.95

78.17

umol/l

97.57

13722

123179

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

305

1077

2.73

56.53

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

13.57

56.30

12.1

8.1

158.51

468.44

e6/l

0.57

(3002385) Erythrocyte distribution width [Ratio]

11207

97348

1.34

55.37

40.3

16.2

15.50

15.32

1.79

11073

95249

(4062490) Immunoglobulin typing, IgG

294

1034

2.74

54.93

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

469

2054

2.21

54.45

3.1

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

21.10

54.07

1.2

1.1

—

mmol/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

227

700

3.12

53.75

1.6

8.86

6.52

u/l

1.05

179

553

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

263

883

2.87

53.61

1.4

13.95

12.83

u/l

1.70

253

845

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

12379

109364

1.37

53.36

33.6

13.0

73.40

77.39

ml/min/173m2

55.09

10999

90048

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

253

834

2.92

53.32

1.4

1.2

1.30

1.41

nmol/l

0.86

228

751

(3004775) Volume in Urine collected for unspecified duration

258

860

2.89

53.29

2.3

2.2

752.02

650.48

2.77

169

558

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

136

6.33

53.04

2.4

2.9

100.93

47.40

mg/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

441

1915

2.23

52.28

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

491

2226

2.14

52.25

1.6

3.51

4.03

iu/l

0.70

149

709

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

142

326

4.18

52.21

3.0

2.3

139.68

145.25

nmol/l

0.25

112

281

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

171

449

3.66

52.16

1.4

60.92

64.29

0.57

137

369

(3017937) Magnesium [Moles/time] in 24 hour Urine

19.09

51.84

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

290

1045

2.67

51.70

1.3

2.64

3.01

g/l

2.81

193

716

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

11.72

51.61

3.5

4.4

2.19

2.39

mg/l

0.19

(3024891) Influenza virus A+B Ag [Presence] in Specimen

554

2642

2.03

51.52

1.3

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

289

1044

2.67

51.27

1.3

0.42

0.45

g/l

0.46

192

717

(3027135) IgG subclass 1 [Mass/volume] in Serum

289

1046

2.66

51.08

1.3

7.04

6.89

g/l

0.16

195

718

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13684

123225

1.46

50.88

18.6

10.1

25.96

25.41

u/l

1.07

13335

117601

(3016750) Collection duration of Urine

205

615

3.20

50.84

2.2

2.1

511.43

499.64

min

0.81

143

444

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

411

1757

2.26

50.60

1.3

36.81

37.39

u/l

0.04

344

1509

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

402

1703

2.28

50.57

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

218

682

3.07

50.39

2.0

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

183

515

3.41

50.29

1.4

1.19

1.20

nmol/l

0.04

141

407

(37019676) Renin [Units/volume] in Plasma --supine

20.68

49.77

1.1

1.3

56.07

25.71

mu/l

0.53

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

618

3100

1.94

49.74

1.7

1.5

1.26

6.68

iu/ml

1.21

143

693

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

212

660

3.09

49.42

1.3

102.98

85.24

u/l

1.55

189

560

(3011412) CD3 cells [#/volume] in Blood

274

985

2.68

49.09

2.0

2.4

1.48

1.12

e9/l

0.54

254

890

(3003694) ABO and Rh group [Type] in Blood

3871

29405

1.34

48.92

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

220

704

3.00

48.91

3.6

3.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

208

645

3.10

48.82

1.3

30.08

22.88

u/l

1.25

181

535

(3017704) Immunofixation for Urine

195

584

3.21

48.52

1.5

1.6

—

(3022145) Colonoscopy Study observation

1891

12767

1.47

48.03

1.4

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

124

275

4.32

47.72

2.3

2.4

1.06

1.07

ug/l

0.02

119

261

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

189

562

3.23

47.59

2.5

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

180

522

3.31

47.20

3.7

2.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

132

313

4.04

46.53

1.3

1.4

17.91

15.81

pmol/l

0.82

103

262

(3014148) Varicella zoster virus Ab [Titer] in Serum

267

974

2.64

46.49

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

197

613

3.09

46.00

5.2

3.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

734

3989

1.79

45.83

1.2

1.00

0.92

u/ml

0.05

369

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

179

527

3.26

45.82

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1100

6668

1.61

45.76

2.6

2.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

137

341

3.85

45.18

1.3

21.13

21.21

0.01

124

304

(3051611) Lipemic interference index of Serum or Plasma

301

1180

2.46

45.14

4.8

2.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

147

389

3.62

44.40

1.4

3.21

2.66

0.33

126

322

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

142

5.66

44.28

1.1

2.59

22.86

pmol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

556

2803

1.92

44.07

1.8

1.9

11.86

11.24

mg/l

0.81

501

2581

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

245

880

2.68

44.01

1.6

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

205

5042

0.38

43.98

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

360

1556

2.23

43.20

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

186

581

3.07

43.17

1.2

1.1

33.62

23.15

u/l

1.59

175

510

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

230

818

2.70

42.14

1.1

1.2

94.52

170.59

titre

1.96

152

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

607

3196

1.84

42.04

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

335

1422

2.27

41.99

3.8

2.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

188

602

3.00

41.81

1.3

1.2

284.00

374.54

u/l

0.47

170

563

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

253

948

2.57

41.77

1.5

1.6

31.54

25.75

u/ml

0.71

207

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

229

817

2.69

41.71

1.1

1.2

75.00

166.57

titre

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

184

583

3.03

41.69

1.2

1.1

97.85

82.65

u/l

1.19

174

516

(3004716) Salmonella sp identified in Stool by Organism specific culture

792

4534

1.70

41.10

1.4

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

128

325

3.77

41.08

1.3

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

187

604

2.97

40.97

1.7

1.8

—

(3000330) Specific gravity of Urine by Test strip

978

5938

1.61

40.29

5.7

3.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

186

605

2.95

40.26

1.7

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

205

704

2.80

40.18

2.0

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

330

1419

2.24

40.12

1.1

97.08

7363.35

iu/ml

0.53

320

(3006922) Hepatitis E virus Ab [Presence] in Serum

193

644

2.88

39.90

1.1

—

(3045414) Leukocytes [Presence] in Urine

867

5123

1.65

39.85

2.6

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

981

5989

1.60

39.48

1.4

1.3

349.28

238.07

u/ml

1.27

905

5489

(1175426) CD3 cells/100 lymphocytes in Blood

214

760

2.70

39.35

2.0

2.1

73.71

71.30

1.28

207

723

(21494815) CD4 cells/100 lymphocytes in Specimen

225

822

2.63

39.13

2.1

2.2

40.25

38.17

1.02

216

806

(3047189) Immunofixation for 24 hour Urine

159

482

3.16

38.87

1.6

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

441

2170

1.96

37.56

1.5

1.4

12.71

10.83

u/l

1.46

358

1765

(3017732) Neutrophils [#/volume] in Blood

1223

7937

1.51

37.35

4.3

2.9

5.84

5.02

e9/l

0.85

889

6151

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

147

436

3.23

37.27

1.3

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

15.74

37.15

3.5

4.3

—

(3042517) Benzodiazepines panel - Urine

9.33

36.05

2.3

2.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

144

435

3.17

35.45

15.7

12.0

0.68

0.63

mmol/l

1.56

130

395

(3018133) Calcium [Moles/volume] in Urine

130

5.29

35.43

1.9

1.8

1.98

2.71

mmol/l

2.12

113

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

132

379

3.34

35.28

2.3

1.7

3496.00

27144.61

u/ml

0.62

(3012898) Urea [Moles/volume] in Urine

6.40

35.28

1.4

109.57

180.89

mmol/l

4.11

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

294

1273

2.22

35.19

3.1

3.3

10.38

11.44

nmol/l

0.09

285

1240

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

176

599

2.82

35.14

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

178

610

2.80

35.09

3.8

3.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

135

5.17

34.99

3.3

3.2

37.89

42.60

umol/l

0.98

111

(3020717) Zinc [Moles/volume] in Serum or Plasma

149

463

3.08

34.98

2.4

1.4

16.00

26.73

umol/l

5.52

141

438

(3023410) Appearance of Cerebral spinal fluid

231

903

2.46

34.96

1.8

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

176

601

2.81

34.93

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

166

550

2.89

34.82

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

166

550

2.89

34.82

1.3

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

108

274

3.77

34.77

1.9

1.6

—

(3049717) Cytology report of Urine Cyto stain

814

4903

1.61

34.58

2.5

2.8

—

(3010503) CD19 cells [#/volume] in Blood

183

643

2.73

34.41

2.1

2.5

0.68

0.28

e9/l

0.48

177

621

(3006576) Bicarbonate [Moles/volume] in Blood

124

349

3.40

34.21

6.9

6.0

24.95

24.94

mmol/l

0.01

114

309

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

269

3.77

34.12

1.2

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

108

5.66

33.86

1.6

2.0

1.30

1.69

mmol/l

0.48

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

125

5.27

33.84

2.0

18.51

17.06

umol/l

0.41

125

(1761482) Bacteria [#/volume] in Urine by Culture

569

3144

1.75

33.52

6.6

4.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

153

495

2.96

33.51

1.2

1.1

3.91

3.66

iu/ml

0.13

(36660697) Celiac disease serology panel - Serum

1208

8019

1.47

32.85

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

6.86

32.52

2.2

1.9

14.95

22.26

0.56

(40768441) Liver Pathology biopsy report

203

774

2.52

32.43

1.6

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

105

276

3.64

32.15

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

359

3.28

32.07

1.1

1629.84

1482.42

miu/ml

0.68

123

359

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

229

3.93

32.06

1.5

1.2

—

(3028433) Virus identified in Specimen by Culture

124

365

3.25

31.90

1.3

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

51.80

31.49

8.0

10.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

760

4605

1.60

31.47

1.1

311.43

208.46

titre

0.23

123

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

179

4.33

31.44

1.2

1.5

545.89

741.54

mu/l

0.26

171

(3001186) Copper [Moles/volume] in Serum or Plasma

204

4.08

31.26

1.6

1.2

17.44

16.80

umol/l

0.29

180

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

581

3295

1.71

31.18

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

282

1265

2.14

30.96

1.4

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12520

112978

1.28

30.90

5.8

4.6

6.34

5.95

mmol/l

98.36

11262

100953

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

9.54

30.80

6.9

3.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

129

4.96

30.72

1.5

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

105

285

3.52

30.67

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

192

733

2.51

30.62

2.2

1.5

93.56

84.60

umol/l

1.05

192

733

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

183

4.23

30.57

1.2

1.5

74.67

70.91

1.54

175

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.81

30.48

2.5

1.9

54.66

56.19

0.08

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

126

386

3.13

30.37

3.3

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

135

432

2.99

30.20

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

111

317

3.35

29.99

1.6

1.3

3.02

3.51

umol/l

0.80

101

288

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

174

4.28

29.93

1.4

10.39

11.18

0.10

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

190

730

2.50

29.91

2.0

2.6

909.65

630.49

e6/l

0.52

177

700

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

183

691

2.54

29.87

1.9

2.6

688.05

498.03

e6/l

0.46

154

583

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

108

305

3.39

29.70

1.3

26.47

20.62

0.26

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

209

842

2.38

29.68

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

124

4.93

29.15

1.6

1.3

—

(3026726) Creatinine [Moles/volume] in Specimen

6.01

28.73

2.8

1.9

258.41

394.99

umol/l

0.27

(3022621) pH of Urine by Test strip

1154

7790

1.44

28.63

4.3

3.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

192

757

2.43

28.61

2.8

3.5

186.15

153.74

nmol/l

0.43

184

742

(3026389) Candida sp identified in Specimen by Organism specific culture

332

1631

1.96

28.49

1.3

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

672

4055

1.60

28.30

1.1

0.88

8.15

u/ml

0.63

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

278

3.44

28.20

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

101

283

3.41

28.14

1.1

—

(3045424) Erythrocytes [Presence] in Urine

371

1907

1.87

27.79

1.8

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

13932

127879

1.34

27.71

51.6

20.6

37.05

40.12

211.78

12977

118352

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

144

502

2.75

27.59

1.2

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

121

385

3.01

27.38

1.7

1.5

2178150.80

1544552.25

iu/ml

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

174

670

2.49

27.30

1.9

2.7

0.19

0.24

e9/l

2.36

155

582

(3007461) Platelets [#/volume] in Blood

13933

127946

1.34

27.13

51.0

20.5

256.71

246.51

e9/l

45.85

13658

123844

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

232

1020

2.18

26.86

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

559

3265

1.65

26.85

1.7

—

(3010813) Leukocytes [#/volume] in Blood

13936

128021

1.34

26.69

51.0

20.5

7.44

6.72

e9/l

112.84

13619

123442

(3033923) Metanephrine [Moles/time] in 24 hour Urine

220

3.69

26.69

1.1

0.74

0.66

umol/24h

0.65

(3032057) Clostridioides difficile [Presence] in Stool

261

3.44

26.59

2.0

1.7

—

(3024731) MCV [Entitic volume]

13934

128011

1.34

26.58

50.8

20.4

91.61

91.36

7.32

13750

125486

(3035941) MCH [Entitic mass]

13933

128001

1.34

26.58

50.8

20.4

30.44

30.38

3.58

13744

125481

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

326

1631

1.92

26.54

1.8

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

13934

128022

1.34

26.47

51.0

20.5

4.15

4.46

e12/l

307.65

13618

123439

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

246

1114

2.12

26.43

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

183

3.97

26.41

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

123

404

2.91

26.33

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

138

483

2.74

26.27

1.7

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

138

483

2.74

26.27

1.7

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

13934

128044

1.33

26.25

51.5

20.6

124.81

134.80

g/l

307.65

13747

125538

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

223

3.64

26.18

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

491

2.71

26.00

1.8

2.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

6.57

25.79

1.1

1.3

973.69

1345.04

u/l

0.11

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

334

1704

1.89

25.64

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

192

796

2.31

25.61

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

618

3744

1.60

25.61

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

107

331

3.09

25.45

2.1

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

115

373

2.95

25.20

1.3

3.48

3.34

mmol/l

0.13

101

343

(40768804) Tissue Pathology biopsy report

5638

47551

1.20

24.90

2.3

2.1

—

(3003129) Base excess in Capillary blood by calculation

294

3.19

24.55

2.2

1.8

-0.13

0.83

mmol/l

0.88

280

(4281824) Cell count and differential, peritoneal fluid

260

1241

2.01

24.29

1.3

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

119

404

2.82

24.03

2.0

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

260

3.31

23.97

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

191

814

2.25

23.91

2.2

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

238

3.41

23.78

2.2

2.7

—

(3021788) Differential panel - Synovial fluid

404

2247

1.73

23.33

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

270

3.22

23.23

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

268

1314

1.96

23.22

1.3

1.2

4.92

3.73

u/ml

0.66

121

577

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

162

654

2.37

23.01

1.3

1.4

15.35

13.13

umol/l

1.97

151

615

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

115

393

2.80

22.96

1.5

2.1

172.19

153.97

1.12

109

368

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

149

583

2.45

22.68

1.4

1.6

6.14

5.94

u/l

0.11

117

484

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

265

3.21

22.61

1.2

—

(40757373) Influenza virus identified in Isolate

212

3.47

22.13

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

246

1191

1.98

22.12

1.6

1.5

20.04

29.78

5.67

151

714

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

143

558

2.45

21.91

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.90

21.85

2.9

2.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

161

667

2.31

21.60

2.0

1.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

188

832

2.17

21.51

1.3

546.25

557.04

titre

0.01

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

231

3.31

21.37

2.1

2.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

183

806

2.18

21.20

1.3

42.73

75.44

titre

1.30

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

306

2.97

21.15

1.4

1.3

21.55

24.22

0.37

259

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

196

3.51

21.07

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

131

502

2.50

20.89

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

120

443

2.59

20.67

2.6

3.3

22.80

26.90

mu/l

0.50

113

413

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

319

1718

1.78

20.65

2.5

2.1

2890.87

4400.86

u/l

0.59

109

650

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

237

1163

1.95

20.54

3.6

3.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

489

2961

1.59

20.35

1.7

1.6

14569.07

14433.17

e6/l

0.03

353

2166

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

157

661

2.27

20.31

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

905

6217

1.41

20.27

1.2

101.65

135.19

iu/ml

2.31

306

2264

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

140

3.96

20.18

2.1

2.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

155

653

2.27

20.03

1.4

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

207

980

2.02

19.87

3.4

2.6

106.09

25.19

mg/l

3.49

151

671

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

15.26

19.46

3.5

4.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

132

3.98

19.30

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

4.14

19.22

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

108

4.33

19.21

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

260

1346

1.85

19.19

1.3

1.2

4.41

4.47

u/ml

0.02

469

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

6.36

19.09

1.7

1.5

151.68

161.90

ug/g

0.08

(3014891) Appearance of Pleural fluid

155

3.70

19.00

1.3

1.2

—

(21494434) Karyotype in Bone marrow

209

1011

1.98

18.92

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

165

732

2.16

18.83

2.3

1.9

13.81

9.68

umol/l

1.01

132

529

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

154

665

2.22

18.79

1.1

338.08

287.20

mg/l

0.82

131

582

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2305

18227

1.24

18.57

1.3

41.41

36.90

iu/ml

0.62

755

5840

(3042010) Triglyceride [Moles/volume] in Pleural fluid

167

3.54

18.49

1.3

1.2

1.80

1.57

mmol/l

0.09

104

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

124

4.00

18.42

1.2

1.3

7.07

308499.10

nmol/l

0.91

106

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

32.69

18.41

5.2

5.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

781

5320

1.42

18.35

1.8

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

254

3.01

18.33

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

158

698

2.17

18.24

1.2

1.1

45.92

40.93

mg/l

0.70

128

586

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

275

2.92

18.24

1.5

0.35

0.39

ug/l

0.50

171

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

276

2.91

18.12

1.3

116.46

135.05

nmol/l

0.57

201

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

147

3.70

18.12

2.1

2.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

110

4.16

17.92

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

467

2885

1.56

17.87

1.3

73.19

39.21

u/ml

1.00

182

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

123

3.96

17.80

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

151

663

2.18

17.72

2.4

1.9

2.58

3.00

u/field

0.16

119

433

(3052592) Norovirus Ag [Presence] in Stool

239

3.04

17.71

1.4

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

489

3059

1.54

17.69

3.8

2.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

434

2644

1.58

17.65

1.3

5.18

5.88

u/ml

0.10

291

(3023420) DNA double strand Ab [Units/volume] in Serum

206

1018

1.94

17.57

1.7

1.5

42.15

23.96

iu/ml

0.50

(21491868) Cryoglobulin [Mass/volume] in Serum

362

2.61

17.47

1.3

1.2

0.16

0.18

g/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

147

3.64

17.36

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

134

565

2.27

17.35

2.9

2.8

38.20

38.23

0.01

334

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

134

3.78

17.34

1.3

1.4

76.65

70.18

0.80

109

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

354

2.62

17.19

1.2

1.3

161.11

352.82

ug/l

0.65

203

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.09

17.18

6.3

7.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

2080

0.40

17.09

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

146

644

2.17

16.96

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

267

2.86

16.81

1.1

85.10

86.35

0.09

136

(3022229) Phosphate [Moles/volume] in Urine

6.15

16.76

1.3

2.1

14.02

14.08

mmol/l

0.01

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

151

3.54

16.71

1.2

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

4.98

16.70

1.5

1.3

16.97

19.67

pmol/l

0.24

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

433

2678

1.55

16.51

1.3

4.29

4.67

u/ml

0.16

454

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

16.53

16.40

3.2

3.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

285

1593

1.72

16.31

1.6

66.94

58.60

3.09

173

996

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

205

1041

1.89

16.15

2.2

2.1

2.43

2.26

u/field

0.16

103

376

(3051593) INR in Capillary blood by Coagulation assay

141

626

2.15

16.14

7.7

11.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

241

3943

0.58

16.13

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

355

2.56

16.08

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

274

2.79

16.05

1.1

83.78

86.11

0.22

136

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.22

15.98

1.1

1.87

1.63

umol/24h

0.55

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

249

2.88

15.94

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.26

15.80

1.4

1.3

58.84

41.89

mg/l

0.79

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

112

456

2.35

15.77

1.1

1.12

1.07

u/l

0.24

215

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

106

422

2.40

15.70

1.1

523.80

661.44

ng/l

0.17

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

371

2241

1.59

15.69

1.3

1.2

3.53

4.79

u/ml

0.32

181

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

553

2.21

15.69

1.5

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

144

3.51

15.66

1.3

1.2

221.81

98.96

u/l

0.59

101

(3017509) Phencyclidine [Presence] in Urine

5.17

15.51

1.4

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.52

15.38

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

226

2.92

15.05

1.2

1.46

1.71

mmol/l

0.87

130

(44786800) Granulocytes/100 leukocytes in Body fluid

167

3.26

15.00

1.4

22.61

23.36

0.06

131

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

231

1248

1.77

14.94

1.1

119.03

116.13

0.54

207

1119

(43055514) Macroprolactin [Presence] in Serum or Plasma

140

3.48

14.85

1.2

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

444

2828

1.51

14.83

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

101

3.97

14.77

1.2

1.3

—

(3051339) Copper [Moles/volume] in Blood

5.45

14.36

1.9

1.1

15.82

17.32

umol/l

0.59

(3006245) CD3-CD19+ cells/100 cells in Blood

364

2.44

14.33

2.1

2.3

10.06

11.52

0.56

331

(3018851) Theophylline [Moles/volume] in Serum or Plasma

108

3.80

14.26

1.6

1.7

50.02

48.23

umol/l

0.11

108

(3044941) Cell count panel - Synovial fluid

315

1875

1.61

14.21

1.5

1.4

—

(40768443) Skin Pathology biopsy report

760

5382

1.36

14.18

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2152

24032

0.83

13.95

2.9

3.1

0.81

0.78

ug/l

0.43

1554

16442

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.93

13.92

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2066

16611

1.21

13.84

16.2

7.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.34

13.83

1.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

21.18

13.82

6.9

9.7

106.43

1260.33

e6/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.23

13.77

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

412

2627

1.51

13.72

1.1

22.39

9.46

u/ml

0.38

259

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

204

1091

1.79

13.70

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

4.62

13.68

1.2

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

148

3.29

13.66

1.6

56.53

65.86

pmol/l

0.25

117

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

195

1030

1.81

13.64

1.6

1.4

31.24

29.91

u/l

0.18

156

839

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

781

5595

1.35

13.53

4.4

3.7

88.82

71.06

u/ml

0.70

745

5382

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

146

707

1.98

13.33

1.2

1.3

9.30

8.85

mmol/l

0.59

139

672

(3048879) Bone marrow aspiration report

389

2.33

13.29

1.4

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

114

3.60

13.22

1.9

2.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.90

13.08

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

192

2.93

13.07

1.7

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

218

2.80

13.05

2.4

1.3

152.37

102.56

ng/l

1.77

218

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

284

1690

1.61

12.87

2.6

2.1

31.00

25.75

mg/l

0.64

457

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

171

885

1.85

12.81

2.3

2.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

171

887

1.84

12.72

2.0

1.8

5.64

3.81

mg/l

3.33

158

836

(3004616) Nuclear Ab [Presence] in Serum

243

1395

1.67

12.71

1.4

1.3

—

(4200892) Spirometry reversibility

1129

8585

1.27

12.60

1.5

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

217

2.77

12.60

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

186

2.92

12.58

1.8

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

130

618

2.01

12.54

1.6

1.5

1.58

3.51

2.69

134

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

114

3.51

12.49

2.5

3.2

1.51

1.25

mg/l

0.36

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

6.26

12.36

1.1

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

231

1320

1.68

12.31

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

183

981

1.79

12.25

1.6

1.4

0.25

0.32

nmol/l

0.88

138

712

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

130

3.30

12.18

1.1

15.81

19.34

u/l

0.84

(4146454) Self-monitoring of blood glucose

221

1253

1.69

12.13

3.0

2.5

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

0.63

1.67

mg/l

0.63

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

2.03

2.23

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

1.24

2.13

mg/l

0.52

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

2.25

4.17

mg/l

0.71

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

1.02

1.72

mg/l

0.33

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

1.99

1.54

mg/l

0.20

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

5.11

3.19

mg/l

0.49

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

3.33

2.41

mg/l

0.26

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.07

11.89

1.2

1.6

2.11

2.47

mg/l

0.11

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

326

2.37

11.83

2.0

3.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

435

2.17

11.77

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2107

17224

1.19

11.68

1.3

1.2

11.71

14.54

u/ml

0.98

720

6385

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

320

2010

1.53

11.52

1.3

1.2

50.37

44.68

u/ml

0.22

208

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.32

11.45

1.0

1.1

1.36

0.97

u/field

1.42

(3006270) Folate [Moles/volume] in Blood

187

1031

1.74

11.40

1.2

335.09

342.03

nmol/l

0.16

143

840

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.86

11.36

1.2

1.6

2.14

1.58

mg/l

0.17

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

143

3.07

11.08

4.2

2.4

0.63

0.61

u/field

0.05

143

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

171

927

1.76

11.07

1.1

99.42

94.55

1.56

157

864

(3013336) Amino acids [Identifier] in Serum or Plasma

14.30

10.95

6.2

2.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

405

2.17

10.92

1.1

31.20

17.00

u/ml

0.35

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

121

592

1.95

10.83

1.1

7.64

7.59

nmol/l

0.00

127

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

12.07

10.77

7.4

4.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11734

107999

1.14

10.62

4.7

3.9

1.35

1.26

mmol/l

27.18

10485

96473

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

4.29

10.58

1.1

53.00

43.12

u/l

0.29

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.99

10.30

1.1

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

556

6999

0.75

10.06

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

162

2.83

10.05

1.6

1.5

105.95

113.08

ug/l

0.17

134

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

178

2.73

10.03

2.5

3.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

112

550

1.95

9.95

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

241

2.46

9.84

15.5

6.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

870

6610

1.27

9.80

1.2

1.3

58.34

57.54

au/ml

0.02

383

(3001964) Herpes simplex virus Ag [Presence] in Specimen

307

2.27

9.73

1.5

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

947

7274

1.26

9.73

2.3

2.4

16.32

25.51

au/ml

2.02

479

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

129

3.03

9.72

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

313

2031

1.48

9.71

1.3

185.41

215.41

miu/ml

0.50

851

(1761868) Lipid panel - Serum or Plasma

3446

36211

0.88

9.65

3.7

2.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

110

3.21

9.63

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

102

494

1.97

9.46

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

152

2.82

9.43

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

264

2.35

9.39

2.1

2.3

149.33

798.24

e6/l

1.29

142

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

312

2.23

9.38

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

174

2.69

9.36

1.3

97.75

605.10

ng/l

0.58

120

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

186

2.62

9.25

1.2

82.58

78.02

0.22

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

199

1183

1.61

9.21

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

+∞

9.20

2.3

0.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

374

2537

1.41

9.18

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

199

2.54

9.07

2.8

2.7

3040.02

1712.13

u/l

0.30

180

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

134

721

1.78

8.99

1.2

1.3

1.45

1.89

u/ml

0.27

422

(3023323) Follitropin [Units/volume] in Serum or Plasma

422

2935

1.38

8.95

1.6

1.4

29.22

32.52

iu/l

1.04

354

2525

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

271

2.29

8.88

2.1

2.4

7.20

7.17

mmol/l

0.02

159

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

156

880

1.69

8.87

1.5

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

147

2.79

8.84

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

267

2.29

8.73

1.2

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

298

2.21

8.68

1.1

1.3

114.40

111.67

0.35

265

(3020491) Glucose [Moles/volume] in Blood

146

814

1.71

8.67

1.8

1.9

7.68

6.93

mmol/l

1.33

102

555

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.01

8.67

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.50

8.66

1.6

1.2

0.83

1.12

ml/s/173m2

0.70

(3033086) Enterovirus NOS Ab [Titer] in Serum

7.06

8.56

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

102

513

1.90

8.52

1.2

1.6

8.76

9.65

ug/l

0.22

466

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

319

2.15

8.51

1.1

1.3

0.33

0.31

g/l

2.51

252

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

114

3.01

8.48

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

144

805

1.71

8.48

1.6

1.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.19

8.42

1.0

1.1

9798.80

3101.33

ng/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

284

2.22

8.39

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

203

2.44

8.25

16.7

6.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

186

2.51

8.24

1.2

70.24

73.43

0.18

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

2.89

8.14

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

222

2.36

8.12

2.1

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

204

1261

1.55

8.05

1.2

1.3

37.07

61.03

u/ml

1.12

(3012920) Ethanol [Mass/volume] in Serum or Plasma

10.21

8.01

1.5

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

103

3.05

7.99

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

167

2.57

7.94

1.2

1.3

42.94

51.38

0.42

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

104

1748

0.56

7.92

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.14

7.87

3.5

2.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.64

7.78

1.8

5.4

16.33

13.96

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

319

2.09

7.74

5.0

5.3

65.20

70.31

0.68

249

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

159

939

1.62

7.64

1.3

1.2

35.70

41.36

u/ml

0.17

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.88

7.63

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3210

33469

0.89

7.59

4.2

4.4

21.81

21.86

0.06

1590

17353

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

420

1.93

7.54

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

133

2.72

7.53

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

158

937

1.61

7.48

1.3

1.2

79.20

78.81

u/ml

0.01

(3038026) Centromere Ab [Units/volume] in Serum

161

961

1.60

7.42

1.3

1.2

35.70

52.51

u/ml

—

(3002256) Pathology report gross observation

1842

15424

1.16

7.42

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

102

538

1.81

7.40

1.1

1.11

1.06

ratio

0.70

186

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

130

736

1.69

7.38

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

288

2.12

7.34

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

288

2.12

7.34

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

288

2.12

7.34

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

288

2.12

7.34

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

282

2.13

7.32

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

398

1.94

7.31

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

129

731

1.69

7.30

1.2

1.1

—

(4034850) Laboratory test

520

3850

1.30

7.29

15.8

10.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

129

732

1.68

7.27

1.2

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

3.85

7.21

1.8

1.4

1.25

1.10

u/field

0.41

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

129

735

1.68

7.16

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

129

735

1.68

7.16

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.97

7.16

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.01

7.12

1.3

1.1

29.67

24.92

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

128

731

1.67

7.05

1.2

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.54

7.02

1.8

2.5

206.97

38.57

pmol/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

150

895

1.60

6.96

1.2

3.33

3.17

u/ml

0.04

(3022689) Creatine [Moles/volume] in Urine

263

2.14

6.95

2.2

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.62

6.93

1.2

1.0

1.59

3.97

u/l

—

(3026480) Teichoate Ab [Titer] in Serum

102

2.90

6.89

1.1

—

2.40

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.14

6.87

1.1

1.4

43.14

37.62

0.20

(3010144) Erythrocytes [#/volume] in Synovial fluid

191

1209

1.51

6.83

1.5

1.4

25439.82

132542.61

e6/l

6.03

134

826

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

105

575

1.74

6.76

2.2

2.1

171.63

59.63

ug/min

0.98

126

(3044009) aPTT.lupus sensitive (LA screen)

3.18

6.75

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

133

777

1.64

6.74

1.1

—

14.53

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

236

2.18

6.70

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

128

743

1.65

6.65

4.0

4.4

165.43

125.90

u/ml

0.17

214

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

371

2657

1.34

6.64

1.4

—

(4212803) Bone marrow aspirate examination

2.94

6.63

1.1

1.0

—

(3007463) Buprenorphine [Presence] in Urine

7.85

6.57

3.0

11.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.57

6.52

1.4

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12433

115721

1.11

6.49

5.6

4.8

2.39

2.75

mmol/l

307.65

11222

104348

(3000492) Spirometry study

1217

9992

1.17

6.34

1.6

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

187

2.29

6.31

1.0

1.2

—

(3024263) Appearance of Synovial fluid

109

620

1.68

6.16

1.6

1.3

—

(40763791) Oxygen content in Venous blood by calculation

5.05

6.16

2.2

5.3

12.81

11.80

ml/dl

0.39

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.13

6.12

2.5

3.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

17.15

6.09

1.1

1.2

23.77

48.20

nmol/24h

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

116

2.63

5.99

1.2

1.3

136.42

109.60

ug/l

0.40

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

252

3287

0.73

5.93

2.3

1.6

4.68

3.79

mg/l

0.59

207

2376

(3033942) Copper [Moles/time] in 24 hour Urine

5.45

5.87

1.1

1.0

0.16

0.41

umol/24h

—

(3019174) dRVVT (LA screen)

3.05

5.87

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

140

2.45

5.86

13.7

9.2

0.33

0.49

umol/l

0.46

130

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

206

2.18

5.84

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.65

5.78

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3344

29444

1.10

5.76

1.8

1.6

1.43

1.31

mmol/l

10.34

2765

23975

(3000285) Sodium [Moles/volume] in Blood

153

2.37

5.75

1.4

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

171

1100

1.49

5.74

1.8

1.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.80

5.69

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.04

5.61

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12134

113016

1.10

5.59

5.1

4.3

4.30

4.67

mmol/l

252.67

10993

102564

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.42

5.55

1.1

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

106

2.61

5.37

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

152

2.32

5.37

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

152

2.32

5.37

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

152

2.32

5.37

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

343

2510

1.31

5.36

5.0

3.3

27.53

28.86

mg/l

0.28

238

1562

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

196

1320

1.42

5.21

3.8

109.04

46.05

u/ml

1.44

190

1292

(3049233) Organic acids panel - Urine

10.72

5.12

1.2

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

156

2.26

5.08

1.1

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

313

1.86

4.97

2.1

1.8

20.79

46.15

u/l

1.82

286

(3013166) Neutrophils/100 leukocytes in Synovial fluid

389

1.77

4.97

1.5

1.3

71.42

55.79

3.46

330

(3050794) Legionella sp Ab [Presence] in Serum

2.77

4.82

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

276

1.90

4.81

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

179

1209

1.41

4.73

1.1

4.01

3.73

u/ml

0.07

472

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

102

2.52

4.72

6.4

4.7

—

(3002619) Bacteria identified in Specimen by Culture

258

1.92

4.71

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

845

0.53

4.70

1.3

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

813

0.53

4.59

1.6

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1032

0.58

4.56

1.5

—

(3032641) Amino acids panel - Urine

13.33

4.44

1.7

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

791

0.53

4.43

1.5

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

305

1.81

4.42

1.4

1.6

10.50

9.03

ug/l

1.00

305

(3050129) First trimester maternal screen panel - Serum or Plasma

1174

0.61

4.38

1.5

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

311

2322

1.28

4.26

1.7

1.4

298.24

173.06

pmol/l

1.41

296

2270

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

703

5712

1.18

4.25

1.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.18

4.22

1.7

1.3

371.38

338.67

umol/24h

0.23

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

125

813

1.47

4.10

1.0

526.60

353.08

ng/l

0.26

542

(40768800) Prostate Pathology biopsy report

217

2726

0.75

4.10

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

218

1560

1.34

4.10

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

125

815

1.46

4.05

1.0

759.20

708.31

ng/l

0.62

520

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.79

4.04

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11979

111951

1.08

4.00

5.1

4.3

1.44

1.49

mmol/l

22.09

10784

100952

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.95

3.98

1.1

1.3

1.18

1.51

0.11

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.68

3.98

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

881

7326

1.15

3.98

1.2

—

(3005033) Fetal Nuchal fold Thickness US

786

0.56

3.95

1.5

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

125

820

1.46

3.94

1.0

31.15

45.89

ng/l

5.93

538

(3035320) C reactive protein [Mass/volume] in Body fluid

126

831

1.45

3.87

3.5

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

494

1.58

3.85

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

495

1.58

3.82

5.3

6.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

138

2.14

3.82

1.9

1.6

—

(3034426) Prothrombin time (PT)

314

1.73

3.78

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

158

2.05

3.76

8.0

6.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

951

0.61

3.72

1.5

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.36

3.70

1.2

1.3

—

247.38

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

781

0.57

3.68

1.4

1.3

97.54

177.67

pmol/l

4.04

781

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1398

14689

0.90

3.66

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

955

0.62

3.60

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

954

0.62

3.59

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

951

0.62

3.55

1.5

1.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.59

3.55

1.1

1.4

28.69

10.96

1.05

(3023436) Glucagon [Mass/volume] in Serum or Plasma

2.75

3.55

1.7

1.2

293.91

183.72

ng/l

0.52

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

624

0.53

3.52

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.64

3.49

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

210

1.86

3.47

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

617

5055

1.17

3.44

1.1

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

7.41

3.43

4.4

1.6

23.39

29.88

umol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.41

3.41

1.8

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.60

3.40

1.1

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.54

3.39

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

9.52

3.39

1.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

9.52

3.39

1.0

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.86

3.36

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.56

3.31

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

242

1.77

3.28

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

229

1.79

3.24

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

6.67

3.24

1.7

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.57

3.20

1.5

371.42

553.20

nmol/l

0.67

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.57

3.16

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

8.16

3.15

1.0

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.41

3.12

1.7

1.9

0.61

0.69

0.10

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.35

3.11

1.2

1.1

7.50

11.89

u/l

0.62

(3011325) HIV 1+2 Ab [Presence] in Serum

2.95

3.08

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.18

3.03

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.61

3.01

1.0

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.58

3.01

1.3

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.58

3.01

1.3

1.2

0.06

0.07

g/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

396

1.57

3.00

1.0

101.38

95.55

0.78

311

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

134

1.99

2.93

1.1

—

(3001729) Color of Synovial fluid

2.15

2.69

1.6

1.7

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.19

2.68

1.5

1.2

23.57

15.67

nmol/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

166

1.84

2.68

1.1

1.3

29.76

44.12

mg/l

1.05

145

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.42

2.66

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

167

1.83

2.63

1.5

1.6

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.76

2.61

1.7

3.6

5.36

2.37

mu/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

372

3005

1.18

2.56

1.9

1.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.28

2.54

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.28

2.54

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

135

1.91

2.53

2.4

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

923

7950

1.11

2.49

2.5

2.1

10.68

12.57

nmol/l

8.74

759

7045

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.99

2.48

1.5

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

6.80

2.46

1.0

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

5.19

2.44

1.7

1.3

1.57

2.15

mmol/24h

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.13

2.40

1.2

2.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

138

1.86

2.39

1.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.07

2.37

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

112

1.96

2.34

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1081

11228

0.91

2.33

1.5

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

750

6416

1.12

2.31

1.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

391

1.49

2.31

1.2

38.69

39.53

g/l

0.15

206

(3020618) Glucose [Moles/volume] in Synovial fluid

2.60

2.31

1.0

4.71

5.30

mmol/l

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.46

2.24

1.1

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

240

1893

1.21

2.20

4.0

3.7

50.37

44.08

u/ml

0.22

231

1837

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

745

0.68

2.16

1.5

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

394

0.56

2.16

1.2

—

(3018291) Platelet Ab [Presence] in Serum

3.70

2.14

1.4

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.70

2.14

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.80

2.14

51.5

5.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

5.29

2.13

1.2

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

306

1.53

2.12

1.9

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

1367

1.24

2.12

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

254

2873

0.84

2.07

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.43

2.05

1.3

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

2.05

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

236

0.44

2.03

1.7

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1022

0.73

2.02

9.7

2.7

13.94

13.20

3.91

1006

(40768795) Lymph node Pathology biopsy report

159

1218

1.25

1.97

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.09

1.96

1.1

—

(36303858) Crystals [Presence] in Urine

3.33

1.95

1.0

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

429

0.60

1.95

1.5

1.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.81

1.94

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1775

15917

1.07

1.93

5.0

4.4

34.48

32.78

7.19

1269

10501

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.33

1.89

1.1

212.08

257.48

nmol/l

0.99

(1002224) Polysomnography panel

316

3480

0.86

1.88

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

309

1.48

1.85

1.5

1.3

26.00

36.38

1.22

210

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

3.57

1.84

1.0

1.1

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

3.57

1.84

1.3

1.1

—

25.24

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.97

1.82

1.7

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.38

1.81

1.1

1.0

0.02

0.11

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

234

1.55

1.80

1.3

1.1

—

(40758292) HTLV I+II Ab panel - Serum

167

1.65

1.79

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

269

2985

0.86

1.79

1.3

—

(44813793) Dust mix specific IgE antibody measurement

713

1.30

1.72

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

126

1.74

1.70

23.5

6.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.28

1.66

1.2

1.5

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.28

1.66

1.7

1.4

0.00

0.46

u/l

—

(3034614) HLA Ag [Interpretation]

3.17

1.66

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

167

1319

1.21

1.61

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

258

1.48

1.57

2.4

2.7

123.14

150.75

au/ml

0.20

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.12

1.55

1.3

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

3.40

1.54

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

270

1.45

1.47

2.8

3.5

6.13

7.77

mg/l

1.06

222

(3036071) Salmonella sp Ab [Titer] in Serum

294

1.43

1.46

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.84

1.43

2.9

4.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1015

0.79

1.40

1.1

2.65

3.68

u/ml

0.36

460

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.61

1.39

1.3

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

113

1.69

1.37

1.4

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

850

0.77

1.36

1.1

1.0

0.10

0.26

u/ml

1.55

243

(3009871) Measles virus Ab [Titer] in Serum

294

1.39

1.29

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

569

1.27

1.25

1.4

1.5

2.29

4.91

ug/l

1.83

444

(3020650) Glucose [Presence] in Urine

288

1.39

1.25

1.8

1.4

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

209

1.46

1.23

1.6

2.8

156.77

145.03

ng/l

0.07

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

294

2491

1.13

1.22

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

106

1215

0.83

1.14

1.1

0.63

1.27

u/ml

1.60

593

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.75

1.12

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

910

0.80

1.12

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

314

0.67

1.10

1.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

114

1.59

1.08

1.1

19.50

18.45

iu/ml

—

(3006462) Nitrate [Presence] in Urine

616

1.24

1.08

5.5

3.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

116

0.49

1.05

3.3

2.9

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.27

1.02

1.2

1.0

2498.00

1767.14

titre

—

(3013762) Body weight Measured

2.27

1.02

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.84

1.02

1.4

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

140

1.50

0.99

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

363

3161

1.10

0.96

1.9

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

704

1.20

0.95

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

115

0.50

0.93

6.7

5.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

239

1.36

0.93

1.4

1.2

0.77

47.02

mg/l

0.99

186

(3023430) Cat dander IgE Ab [Units/volume] in Serum

937

0.83

0.91

1.1

2.30

3.84

u/ml

1.12

360

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.75

0.89

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

113

1249

0.86

1.2

8.41

7.54

mmol/l

2.42

100

1070

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

749

1.18

0.85

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

228

1.34

0.82

1.1

0.80

5.18

u/ml

0.60

120

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

578

1.20

0.81

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.69

0.80

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.51

0.78

1.4

1.2

—

(40765096) Chromosome analysis panel by Banding

383

1.24

0.77

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

110

1.47

0.74

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

209

1.32

0.71

6.0

5.6

—

(40763590) HLA-DQ beta [Type]

1.75

0.71

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.75

0.71

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.90

0.70

1.0

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

104

1.47

0.69

1.1

85.94

80.41

ug/l

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

136

0.63

0.69

1.0

1.1

51.77

62.33

u/ml

—

130

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.83

0.67

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.47

0.67

1.3

1.2

20.78

21.41

mmol/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.76

0.65

1.0

—

(3003338) MCHC [Mass/volume]

9972

94210

1.02

0.65

45.4

18.3

331.73

331.94

g/l

1.24

9885

93306

(46235168) Fasting glucose [Moles/volume] in Blood

131

1.38

0.62

2.1

1.8

8.42

7.23

mmol/l

0.73

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

100

1.43

0.59

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

485

1.18

0.59

1.2

1.3

6.30

5.99

mmol/l

0.87

460

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.68

0.57

1.0

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

142

1.34

0.57

1.3

6.45

6.52

mmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.47

0.56

1.4

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

153

1.31

0.51

1.0

—

(40760410) HLA-B [Type] by High resolution

1.50

0.51

1.0

—

(40760409) HLA-A [Type] by High resolution

1.50

0.51

1.0

—

(3022475) Manganese [Moles/volume] in Blood

1.49

0.48

1.1

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

513

0.85

0.47

1.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.37

0.47

1.0

1.1

0.01

0.36

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

131

1.31

0.45

1.1

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1617

15050

1.03

0.44

1.5

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

6.3

—

0.19

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

221

1.21

0.39

2.4

1.5

3.15

2.19

ug/l

0.51

117

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.36

0.39

1.2

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

515

1.13

0.38

5.1

4.1

42.91

10428.94

u/ml

0.51

(3005082) Progesterone [Moles/volume] in Serum or Plasma

204

0.79

0.38

1.3

15.26

30.77

nmol/l

2.09

178

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

268

2687

0.95

0.36

1.9

1.7

48.96

43.64

nmol/l

2.10

258

2589

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.46

0.36

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.26

0.36

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.39

0.35

1.0

—

(3013862) HLA-DP [Type]

1.39

0.35

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.36

0.31

1.4

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

129

1312

0.94

0.30

1.1

1.76

0.81

u/ml

0.41

572

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.28

0.30

12.0

9.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

123

1.24

0.29

1.9

1.5

—

(3025577) Chromium [Mass/volume] in Blood

917

0.92

0.29

2.0

1.90

2.42

ug/l

1.15

773

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

582

1.10

0.29

1.1

9.89

10.78

iu/ml

0.11

125

(3025130) Human papilloma virus identified in Specimen

115

1023

1.07

0.28

1.6

—

(3008898) HLA-B27 [Presence]

290

2873

0.96

0.27

1.1

—

(3015183) Erythrocyte sedimentation rate

406

0.89

0.26

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.68

0.26

1.4

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

562

0.91

0.24

1.3

1.53

1.57

g/l

0.33

562

(3029396) Erythrocyte agglutination [Presence] in Blood

127

1.20

0.23

1.6

2.7

—

(3010937) Rubella virus Ab [Presence] in Serum

1.32

0.23

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

480

0.91

0.22

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

136

1361

0.95

0.22

1.1

2.20

4.09

u/ml

1.69

684

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.20

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.19

0.19

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

384

1.09

0.19

1.1

1.0

0.33

2.58

u/ml

0.81

105

(40762814) Titanium [Mass/volume] in Blood

275

1.11

0.19

1.9

2.3

3.48

3.52

ug/l

0.03

102

(42870560) Thyrotropin [Units/volume] in Cord blood

1.14

0.19

1.0

18.22

7.06

mu/l

—

(3026470) Cobalt [Mass/volume] in Blood

944

0.95

0.18

1.9

3.42

3.86

ug/l

0.25

868

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

208

1915

1.03

0.17

2.0

1.8

173.44

202.13

pmol/l

3.37

190

1800

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

243

2380

0.97

0.16

1.4

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

283

0.91

0.15

3.5

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

252

1.10

0.15

7.9

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

232

0.90

0.14

1.2

1.1

9.21

12.38

u/ml

0.29

120

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

291

1.08

0.13

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

440

1.06

0.12

1.1

1.0

2.67

1.54

u/ml

0.25

115

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

154

1507

0.97

0.11

1.1

1.28

1.98

u/ml

0.56

767

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.16

0.10

1.8

2.9

—

(40768793) Breast Pathology biopsy report

275

2574

1.02

0.09

1.3

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.03

0.09

1.2

0.26

0.89

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.08

0.08

1.2

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.82

0.08

1.2

—

(40758358) Immune stain study

0.81

0.08

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

494

1.04

0.08

1.1

8.89

6.26

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

126

1228

0.98

0.08

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.88

0.06

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4370

41683

1.00

0.05

4.7

5.2

3.50

3.71

ug/l

0.24

3821

37105

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

105

1.09

0.04

1.3

1.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

115

1.08

0.04

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

127

1223

0.99

0.03

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

448

1.00

0.00

1.1

0.55

2.07

u/ml

1.23

150

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

348

0.98

0.00

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

529

1.01

0.00

1.2

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

17.16

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FLUIDELECTRO and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_FLUIDELECTRO	2.069 [1.88, 2.28]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.075

During the follow-up period (1.1.1998 — 31.12.2019), 30904 out of 62802 females with E4_FLUIDELECTRO died.

Males

Parameter	HR [95% CI]	p-value
E4_FLUIDELECTRO	3.843 [3.36, 4.4]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 19521 out of 38323 males with E4_FLUIDELECTRO died.

Mortality risk

Mortality risk for people of age

years, who have E4_FLUIDELECTRO.

N-year risk	Females	Males
1	0.214%	0.689%
5	1.134%	4.028%
10	2.629%	9.432%
15	5.084%	16.832%
20	8.733%	27.242%

Relationships between endpoints

↥

Index endpoint: E4_FLUIDELECTRO – Other disorders of fluid, electrolyte and acid-base balance

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of fluid, electrolyte and acid-base balance

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints